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Abstract
A fundamental tool for containing an epidemic outbreak and mitigating its effects is early
diagnostics. Currently, most of the diagnostic tests are performed by trained staff in central-
ized labs, which are expensive and time-consuming to establish and operate. Lack of access to
such facilities could have devastating effects. The principal motivation behind point-of-care
diagnostic systems is to provide a low cost, fast, sensitive, and specific test in the field which
does not require highly skilled staff to operate.
This thesis describes a magnetic biosensor which takes advantage of a high-T c supercon-
ducting quantum interference device (SQUID) gradiometer sensor and magnetic nanoparticles
(MNPs) to develop a diagnostic unit for point-of-care. Rolling circle amplification (RCA) is
used as the primary molecular amplification method. RCA is an isothermal process with
very high specificity. It is, therefore, easy to implement in a mix and measure concept of
a homogeneous assay. The specific binding of the MNPs to the products of the RCA (i.e.,
DNA coils) changes their relaxation dynamics which is detected by sensitive ac magnetic
susceptibility measurement.
One of the issues with homogeneous magnetic assays, which limits their sensitivity, is the
presence of excess MNP labels in the test sample solution. To mitigate this problem, a novel
technique is introduced, which takes advantage of the geometry of our gradiometer sensor for
a differential ac magnetic susceptibility measurement. In this technique, a negative control
sample and a positive test sample are measured in a single measurement. The differential
measurement virtually removes all of the unbound MNPs in the test sample and is analogous
to the physical washing step typically used in conventional assays. This technique also pro-
vides better signal to noise ratio (SNR) and can detect target concentrations down to tens
of femtomolar levels (45 fM).
To eliminate the use of liquid nitrogen (LN2) for cooling of the SQUID sensor (as it is
not abundantly available in the field) we have shown the successful operation of a SQUID
gradiometer sensor on a commercially available micro-cooler platform. The operation of the
SQUID on the micro-cooler and the high sensitivity of the novel differential ac suscepti-
bility technique, realized in this work, are critical steps towards a homogeneous magnetic
nucleic acid biosensor for rapid detection of diseases. The methods and instruments that
are adopted and presented here are generic and could, in principle, be used for other targets
such as Influenza, Ebola, and Zika. With full implementation of the molecular amplification
on a disposable lab-on-a-chip, the unit would be promising for rapid and highly sensitive
diagnostics at the point-of-care.
Keywords: magnetic bioassay, biosensor, high-T c SQUID, rolling circle amplification, RCA,
magnetic nanoparticle, microfluidics, differential ac susceptibility, diagnostics, point-of-care.
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CHAPTER 1
Introduction
Pandemics can have grave consequences on global human health, eco-
nomics, and well-being [1]. Influenza pandemics are unpredictable and
recurring events with unclear associated global mortality. Influenza-
related mortality is underestimated mostly due to absence of routine
laboratory tests and difficulties in identifying influenza-related deaths.
Models show at least an order of magnitude underestimation in the 2009
pandemic influenza A H1N1 confirmed death count [2]. The pandemic
influenza in 1918 infected half of the world population and caused over
50 million deaths [3]. Today, the world is a different place, and with ad-
vances in science, technology, and medicine, we are not confined to the
limits of the early 20th century health care. The three later pandemics of
influenza that occurred in 1957, 1968, and 2009 did not reach the same
scale nor severity of the 1918 pandemic; however, the threat remains.
Diagnostic tests are now a part of everyday life. They are either used
by the patient at home, like pregnancy tests or glucose monitors, or are
performed in a clinical lab on patient’s samples such as blood, urine,
stool, etc. As an essential part of medical care, they are used for di-
agnosis or exclusion of a particular disease, monitoring the control of
a disease, or screening diseases at pre-symptomatic stage. Early diag-
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nosis is a fundamental component in containing an epidemic/pandemic
outbreak [4]. Lack of access to laboratory diagnostics in low or middle-
income countries is a great challenge which could result in late and/or
incorrect diagnosis and ineffective treatment [5]. However, establishing
a diagnostic laboratory in such environments is a complicated and ex-
pensive task and takes a rather long time during which an outbreak can
become an epidemic. Therefore, the development of a fast, sensitive, and
low cost point-of-care (POC) diagnostic system with high specificity is
crucial for controlling the spread of infectious diseases. The implications
of which is huge in reducing the suffering of the population and the costs
of epidemics on the society, and saving lives.
1.1 Biosensors
Biosensors are powerful tools in the clinical analysis of viruses and var-
ious diseases, where a rapid and timely diagnosis is crucial for public
health. Currently, most of these tests are performed in centralized lab-
oratories using large automated clinical analyzers which are costly and
require specialized staff and long analysis time [6]. To bring these test to
the POC, a user-friendly instrument without the need for trained staff
is required. Biosensors have great opportunity to be used at the POC.
They are analytical devices and consist of a bio-recognition element and
a sensor. These two components are well incorporated, and the interac-
tion of the bio-recognition element with the target analyte is transduced
into a signal which can be measured by the sensor. The bio-recognition
element is responsible for the selectivity of the biosensor [7]. It is made
from a biological or biologically derived materials such as tissues, mi-
croorganisms, enzymes, nucleic acids, antibodies, proteins, aptamers,
etc. [8]. The interaction of the analyte with the bio-recognition element
produces an optical, electrochemical, thermometric, piezoelectric, mass-
based, magnetic, mechanical, or any other effect which the sensor con-
verts into a signal. The most common bio-recognition interactions are
antigen-antibody, enzymatic, cellular (e.g., within or between microor-
ganisms), nucleic acid-based, and biomimetic based interactions [9].
Biosensors can qualitatively and/or quantitatively detect target an-
alytes of both biological (e.g., antibodies, DNA/RNA molecules, pro-
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teins, enzymes, etc.) [10] and non-biological nature (e.g., ions, dissolved
gases, drugs, and toxins) [11]. The application of biosensors is not lim-
ited to the diagnosis of diseases. The diverseness, high sensitivity, and
specificity of biosensors are also crucial for a wide variety of other ap-
plications including health, safety, and environmental assessments such
as pharmaceutical analysis, drug monitoring, clinical pharmacokinetics,
environmental monitoring, and pollutant detection [12].
Nucleic acid assays are a group of biosensors that adopt deoxyribonu-
cleic acid (DNA) as the bioreceptor. They use a single-strand DNA
which hybridizes to its complementary strand with good specificity to
realize the detection of a specific DNA or ribonucleic acid (RNA) target.
These nucleic acid assays can be used to detect pathogens, infection dis-
eases, etc. Functionalized nucleic acids like aptamers and DNA enzymes
have broadened the scope of applications for which they are used, to
detect inorganic and organic molecules and even organisms [13]. Nu-
cleic acid assays are simple and accurate due to the DNA hybridization
technique and therefore, have attracted much attention leading to new
developments and technologies. The sensitivity of these assays depends
mainly on three factors: the efficiency of the DNA sequence hybridiza-
tion, the sequence amplification method, and sensor sensitivity. The hy-
bridization efficiency is affected by the structure of the probe and target
DNA, the hybridization condition and molecular interactions [14]. The
sequence amplification step could be used to reach higher sensitivities
that are required in diagnostic laboratories. There are several amplifica-
tion methods available, such as polymerase chain reaction (PCR) [15],
loop mediated isothermal amplification (LAMP) [16], ligase chain re-
action (LCR) [17], and rolling circle amplification (RCA) [18]. Many
of the signal transduction methods mentioned earlier, e.g., fluorescence,
electrochemistry, among others are currently used in nucleic acid as-
says. However, sensitive signal transduction is still one of the bottlenecks
biosensors face in practical applications.
With advances in nanomaterials, nanotechnology is playing a signif-
icant and increasing role in the development of biosensors [19]. Nano-
materials such as gold nanoparticles [20], carbon nanotubes, magnetic
nanoparticles [21], and quantum dots are now widely used in biosen-
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sors [20]. The new nanotechnology-enabled biosensors provide solutions
in physical, chemical, and biological sensing and have further improved
the detection sensitivity, specificity, multiplexing capability, and porta-
bility of such systems. The application of nanotechnology in biosensors
makes it possible to have biosensor arrays for high throughput paral-
lel measurements, including the integration with microfluidics for lab-
on-a-chip devices [10]. Although commercialization of biosensors lags
the scientific research and patents, many of the hurdles towards POC
tests have been overcome and the number of available POC biosen-
sors for clinical applications has increased [22]. Magnetic nanoparticles
(MNPs) have a wide range of applications in biology and medicine in-
cluding biosensing [23, 24, 25]. Developments in the proper coatings of
MNPs have given them biological recognition functions [26]. Bioassays
based on MNPs have the advantage of real-time detection and low level
of magnetic background signal from the biological samples. They do
not require immobilization or intermediate washing steps, making them
advantageous for biosensing [27]. Using MNPs in biosensing has con-
tributed substantially to the field and its applications. Biosensors based
on these nanomaterials have proven to have advantages in enhanced sen-
sitivity, low limit of detection (LOD), high signal to noise ratio (SNR),
and shorter analysis time compared with non-MNP-based strategies [28].
In sensing applications, MNPs are used in different ways including being
integrated into the transducer materials, substrates for binding, labels,
dispersion of the MNPs in the sample followed by their attraction onto
the active detection surface of the biosensor [29, 30].
There are several magnetic detection techniques used in biosensors for
detecting the MNPs and they can in general be categorized as either
heterogeneous or homogeneous [21, 31]. The heterogeneous biosensors
rely on diffusion of the analytes to the surface of a sensor and can be
extremely sensitive, have a broad dynamic range, and have multiplexing
capabilities [24]. For instance, a high-density giant magnetoresistance
(GMR) sensor has been used to measure the kinetics of antigen-antibody
binding at concentrations of 20 zeptomolar [32]. However, these biosen-
sors are laborious and time-consuming as they require sample and sub-
strate preparations, and multiple washing and incubating steps. Homo-
geneous biosensors, on the other hand, are simple to use with the signal
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generated in the whole sample volume. Examples of such systems with
high sensitivity are the nuclear magnetic resonance (NMR) system [33],
ac magnetic susceptometry [34] and relaxometry using superconducting
quantum interference device (SQUID) biosensors [35]. The homogeneous
biosensors suffer from lower signal levels compared to the heterogeneous
ones. The magnetic signal, in this case, comes from the whole volume
of the sample and attenuates rapidly with distance from the source.
Furthermore, the measurement of a weak detection signal is more chal-
lenging due to the presence of a high level of magnetic background from
unbound magnetic markers.
1.2 Aim and scope
The aim of this work is the development of a sensitive magnetic nu-
cleic acid assay for POC diagnostics. It uses MNP labels, a high-T c
SQUID gradiometer sensor and microfluidic sample handling. Padlock
probe ligation [36] is exploited for target recognition followed by volume
amplification using RCA [18]. The detection of the target nucleic acid
is based on the immobilization of MNP labels on rolling circle products
(RCPs) and is measured using ac magnetic susceptibility. The develop-
ment is a part of the “FLU-ID” grant (No. SBE13-0125) supported by
the Swedish Foundation for Strategic Research, SSF. The ultimate goal
of the project is to develop a portable nano-diagnostics unit for detection
of pandemic influenza. The unit should have low cost, fast response, and
high specificity and sensitivity.
The thesis provides an overview and the background for the work
presented in the appended papers. In Chapter 2, I briefly describe the
relevant elements of magnetic biosensors, including the MNPs we use as
labels, and the ac susceptibility detection approaches. Chapter 3 gives
a short introduction into the principles of nucleic acid detection and
presents the SQUID gradiometer sensors integrated with the microfluidic
chip (i.e., the experimental setup). It also describes the novel differential
ac susceptibility measurement technique we have developed. Chapter 4
includes the results and discussions for two different approaches used
to quantify the target DNAs. Chapter 5 summarizes the performance
of our biosensor and gives an outlook on future work towards a POC
5
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nano-diagnostic unit.
6
CHAPTER 2
Magnetic nanoparticles and
biosensing
2.1 Magnetic nanoparticles
MNPs are used in a broad field of applications including physics, chem-
istry, biology and medicine [23, 37, 38]. They are increasingly used
in biosensors for their unique properties. They are biocompatible, have
both physical and chemical stability [33], and high surface-to-volume
ratio. MNPs are made from a variety of materials such as: iron-based:
maghemite (γ-Fe2O3), magnetite (Fe3O4), MgFe2O4, FePt; cobalt-based:
CoPt, Co; nickel-based: NiFe2O4, NiO; among many others [39]. Iron
oxide MNPs are among the most commonly used magnetic materials
and are prevalent compared to the other MNP materials due to their
biocompatibility and minimal toxicity [40]. Magnetite and maghemite
are both approved by the American food and drug administration (FDA)
as magnetic materials for human in vivo applications [41].
The bio-functionalization of the MNPs with appropriate coating with
biocompatible materials has lead to numerous biomedical applications
of the MNPs. The interaction of the surface coating of the MNPs with
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the biological media such as biological fluids, proteins, cell membranes,
DNA, etc. may change certain properties of the particles’ coating [39].
Therefore, the nature and quality of the coatings are important for the
particles stability and their biomedical applications, especially for in vivo
applications. A few examples of MNP coatings are polymers, proteins,
peptides, oxides, etc. The MNPs we use in our experiments are commer-
cial water/phosphate-buffered saline (PBS) suspended multi-core bion-
ized nanoferrite (BNF) Fe3O4 particles of 100 nm in size from micromod
Partikeltechnologie GmbH. They are prepared via a core-shell method
which embeds the core magnetite in a non-magnetic shell of hydroxyethyl
starch, which is a biopolymer material. The coating of these MNPs with
streptavidin enables the bio-functionalization of the MNPs with different
probing tags.
2.1.1 Magnetic moment of magnetic materials
One of the key parameters of any magnetic material, macroscopic or mi-
croscopic, is the magnetic moment which defines the magnetic strength
of the object. The magnetic properties of the material are due to its
intrinsic magnetic moment defined by the atomic structure and temper-
ature. Magnetic materials are classified into diamagnetic, paramagnetic,
ferromagnetic, antiferromagnetic, and ferrimagnetic, based on their re-
sponse to an external magnetic field [42]. All materials exhibit diamag-
netic properties. Diamagnetism is a weak repulsion of the magnetic
field and is easily overtaken by any other magnetic behavior possessed
by the material. Typical examples of diamagnetic materials are water,
copper, and gold. Paramagnetism is due to uncoupled atomic magnetic
moments in the material which in an external magnetic field aligned
parallel to the direction of the field. The ferromagnetic materials also
have uncoupled atomic magnetic moments but with a tendency to align
in the same direction as one another, forming magnetic domains with a
spontaneous magnetization even in the absence of an external field. The
antiparallel arrangement of these uncoupled atomic magnetic moments
in some materials would result in antiferromagnetism which leaves the
materials with zero spontaneous magnetization. If the antiparallel ar-
rangement of atomic magnetic moments in the material does not have
equal magnitude, the material retains a spontaneous magnetization in
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the absence of the external field and it is known to be ferrimagnetic.
Some of the macroscopic behaviors of the ferrimagnets are similar to the
ferromagnetic materials. Magnetite, maghemite are common ferrimag-
netic materials and most iron, cobalt, and nickel alloys are ferromagnetic.
At the nanoscale, the magnetic properties of materials are different
than in the bulk. The structure of the magnetic domains in the ferro/-
ferrimagnetic materials determines the size dependency of its magnetic
behavior. In bulk, the material has multiple domain structures separated
by domain walls. Reducing the size of the magnetic material below a
critical value, the energy which is necessary to divide into multiple do-
mains becomes higher than the energy needed for the magnetic domain
to be a single domain. This critical size corresponding to the single do-
main depends on the nature of the material and is in the range a hundred
nanometers for magnetite [39]. Since the single domain particles are not
exactly isotropic in their properties, the magnetic moment of the single
domain points to a certain direction. In the absence of applied magnetic
field and magnetic interaction between the particles, the total energy of
a single domain particle with uniaxial anisotropy is:
E = KVpsin2θ (2.1)
where K is the magnetic anisotropy constant, Vp is the particles’ mag-
netic core volume, and θ is the angle between the magnetic moment of
the particle and easy axis [43, 44]. The KVp is the energy barrier that
separates the two equilibrium easy magnetization directions, given by
the two directions of minimum energy (either θ = 0 or θ = pi). The
magnetization lies along either of the two directions of the minimum en-
ergy unless a perturbing force such as thermal agitation can switch the
magnetization by taking it over the energy barrier. For small particles
where this process occurs, the time average of the remanence is zero, and
the particle exhibits properties of superparamagnetism [43]. It is though
important to remember that this observation is intimately related to the
timescale of the observation. In other words, an observed superparam-
agnetic behavior in one experimental timescale may be observed being in
a so-called thermally blocked state in another experimental observation
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with a shorter timescale. The superparamagnetism allows the colloidal
stability of MNP suspension, particle manipulation, and collection upon
exertion of an external magnetic field. Furthermore, in biomedical appli-
cations, where MNPs are used in a liquid suspension form, the random
reorientation of the particles in the liquid suspension can also make a
thermally blocked particle system exhibit superparamagnetic properties.
2.1.2 Magnetic relaxation processes
There are two mechanisms responsible for the relaxation of the magne-
tization of MNPs suspended in a liquid: Brownian relaxation where the
MNPs change their magnetic orientation through a stochastic rotation
of the particle itself and Néel relaxation where the magnetic moment of
the particle changes its orientation within the particle overcoming the
energy barrier due to anisotropy energy, Fig. 2.1. The relaxation associ-
ated with the former is described by Brownian relaxation time, τB, and
is given by:
τB =
3ηVhydro
kBT
(2.2)
where η is the viscosity of the carrier fluid, Vhydro = 34pir
3
H is the hy-
drodynamic volume of the particle including the core and its shell, kB
is the Boltzmann constant, and T is the temperature. The time decay
associated with the latter is called the Néel relaxation time. Assuming a
low applied magnetic field and no interaction between MNPs, the Néel
relaxation time, τN , is given by:
τN = τ0 exp(
KVp
kBT
) (2.3)
where τ0 is a material-specific characteristic relaxation time typically in
the range of 10−12−10−9 s [45]. KVp is the energy barrier between differ-
ent directions of easy magnetization where K is the magnetic anisotropy
and Vp is the particle’s magnetic core volume.
The Néel relaxation time changes the observed magnetic behavior of
10
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Figure 2.1: Illustration of magnetic nanoparticles relaxation mechanisms: (a) Brownian
relaxation due to rotation of the suspended MNP in liquid and (b) Néel relaxation caused by
reorientation of the magnetic moment inside the MNP.
the system with respect to the characteristic experimental measurement
time τexp. If τexp  τN , the system reaches a thermodynamic equilibrium
as the relaxation is faster than the magnetization orientation observed.
The nanoparticles are then considered to be in a superparamagnetic
state. However, for τexp  τN , the particle system is in the thermally
blocked regime, and the magnetization will maintain its direction leading
to a quasistatic state in the measurement time window. In this case, the
particle magnetic moment is locked to itself and can magnetically be
observed via the Brownian relaxation process.
The effective relaxation time of a liquid suspended MNP is a combi-
nation of the two characteristic times and is deduced using:
1
τeff
= 1
τN
+ 1
τB
. (2.4)
The effective relaxation time is dominated by the process with the short-
est characteristic relaxation time. At a particular temperature (e.g.,
room temperature), the Néel relaxation is dominated by intrinsic prop-
erties of the MNP and the Brownian relaxation is dominated by external
properties (i.e., viscosity) [46]. We use multi-core MNP of the particle’s
median size of 100 nm in our experiments. The multi-core MNPs con-
tain several nanocrystals forming the core cluster which have the size of
around 20 nm [47]. The magnetic properties of the particle depend on
the properties of the nanocrystals and how they are distributed in the
core (densely or loosely packed) [46]. The effective magnetic moment of
the multi-core particles, thus, is the vector sum of all nanocrystals in the
11
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Figure 2.2: The Néel , Brownian, and effective relaxation times versus the diameter of the
nanocrystals in the multi-core MNP with hydrodynamic particle size of 100 nm at a fixed
temperature of 300 K with anisotropy constant of K = 40kJ/m3, τ0 = 10−9 and viscosity
of η = 10−3Pa · s [46]. The Brownian relaxation only depends on the hydrodynamic size
of the MNP and is independent of the nanocrystal diameter. For the nanocrystal diameters
smaller than Ds = 18 nm, the effective relaxation is dominated by the Néel relaxation. If
the nanocrystals have diameters larger than DS then the effective relaxation is dominated
by the Brownian relaxation and the MNP will relax through rotation of the particle in the
suspension liquid.
magnetic core [48]. Fig. 2.2 shows the Néel relaxation, Brownian relax-
ation and effective relaxation times for the multi-core 100 nm iron oxide
MNP used in our experiments as a function of nanocrystals diameter in
the core cluster. According to Eq. 2.2, the Brownian relaxation of the
particle only depends on the particle’s hydrodynamic size (≈ 100 nm
in this case) and is thus constant for all nanocrystal core diameter. If
the nanocrystals in the MNP core matrix are smaller than DS = 18 nm,
the MNP relaxes through the Néel relaxation dynamic. For nanocrystal
larger than DS, on the other hand, the effective relaxation is dominated
by Brownian relaxation. Immobilizing these MNPs by freezing drying
results in total disappearance of the Brownian relaxation [46]. This in-
dicates that the MNP system in the dispersion relaxes mostly through
the Brownian relaxation process.
12
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2.2 MNPs as labels for biosensing
Biosensing based on the MNPs is used as an analytical technique to de-
tect variety of biomolecules e.g., DNA, antibody, proteins, etc. [10, 23].
Making use of different magnetic properties of the MNPs, the particles
are used in variety of biosensors using different detection methods [24],
for instance: measuring the the presence of the MNPs by permeability
measurements [49], measuring changes in the hydrodynamic volume of
the MNP [34], or by T2 relaxation nuclear magnetic resonance which
senses the particles surrounding environment [50]. There are also op-
tical methods which use magnetic agitation to detect MNPs optically.
Examples of such methods are: optomagnetic detection using Blu-ray
laser [51], magneto-optical measuring of MNP relaxation time by Cotton-
Mouton effect [52], etc. Another type of detection using MNPs relies on
binding of the MNPs or the target molecules to the surface of the sensor
such as sensors based on Hall effect [53, 54, 55], and giant magnetore-
sistance [32, 56, 57, 58], among others. These biosensors are called
heterogeneous assays with a well-known example of heterogeneous im-
munoassays, the enzyme-linked immunosorbent assay (ELISA). Hetero-
geneous assays, in general, have wide dynamic range and high sensitivity.
However, they are laborious, costly, and require multiple washing and
incubating steps that make them unsuitable for POC diagnostics.
The detection method used in our biosensor is based on determining
the change in the hydrodynamic size of the MNPs by measuring the
change in Brownian relaxation dynamics. There are several methods to
determine the variations in the hydrodynamic size of the MNPs. The
first approach is called magnetorelaxometry [59, 60, 61, 62]. In this
method, an external dc magnetic field is applied to align the MNPs
and the time decay of the sample’s magnetization is monitored after
switching off the external magnetic field. After applying the pulsed-field,
the time decay of magnetization for a MNP system with an effective
relaxation time dominated by Brownian relaxation, is related to the
random reorientation of particles which depends on the hydrodynamic
volume of the particle. It is important to note that this observation is
closely related to the measurement’s timescale. The MNP system could
appear to be superparamagnetic if the timescale of the measurement is
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too long for measuring the remnant magnetization from MNPs in the
quasistatic thermally blocked state. The time decay, on the other hand,
is related to any alteration in the hydrodynamic size of the MNP, due
to binding to target analytes.
The second method is to apply a rotating magnetic field to agitate
the MNP sample [63]. The phase lag between the magnetization of the
samples and the applied rotating magnetic field represents the hydro-
dynamic properties of the MNP system [64, 65]. The third approach,
which we have used in our biosensor, is to apply an external ac magnetic
field to actuate the MNPs. For small amplitudes, the magnetization of
the MNP system is a linear function of the external magnetic field and is
characterized by ac magnetic susceptibility. This approach is proposed
theoretically by Connolly and St Pierre [66] and is shown for the first
time experimentally for prostate-specific antigen [34]. The binding of
the MNPs to the target analytes changes their hydrodynamic size and
according to Eq. (2.2), their Brownian relaxation time. This specific
binding and the induced change in the relaxation dynamic is detectable
through measuring the ac magnetic susceptibility. The ac susceptibil-
ity has very low background signal (as the signal comes only from the
MNP response to the excitation field) and is the center of our detection
method. In the following sections, we explain this method in details.
2.2.1 Ac magnetic susceptibility
The Debye theory describes the frequency dependence of complex sus-
ceptibility of dispersive materials, such as polar molecules and ferroflu-
ids [67]. This theory holds at low applied magnetic field amplitudes
and for spherical particles when the magnetic dipole-dipole interaction
is negligible compared to the thermal fluctuations. According to the
Debye model, the magnetization of a collection of mono-dispersed, non-
interaction particles is given by the complex susceptibility [68]:
M(ω) = χ(ω)Hac, (2.5)
where M(ω) is the complex magnetization, Hac is the applied ac mag-
netic field, ω is the angular frequency of the applied field (ω = 2pif) and
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χ(ω) is the ac magnetic susceptibility [69]:
χ(ω) = χ′(ω)− iχ′′(ω),
χ(ω) = χ0 − χ∞1 + iωτ + χ∞.
(2.6)
The real (in-phase) and imaginary (out-of-phase) parts of the ac suscep-
tibility are given by:
χ′ = χ0 − χ∞1 + (ωτ)2 + χ∞, (2.7)
χ′′ = (χ0 − χ∞)ωτ1 + (ωτ)2 . (2.8)
where χ0 is the static magnetic susceptibility (which depends on the
particle effective magnetic moment [48]), χ∞ is the high frequency sus-
ceptibility, and τ is the characteristic relaxation time. Although the
expressions are borrowed from the Debye theory for the dielectric relax-
ation, one can derive these equations within the framework of the linear
response theory [70]. In a regime where the frequency of the applied ac
magnetic field is comparable to the magnetic relaxation of the system,
the system may show some phase lag (dissipation). The relaxation time
of the system can be extracted at ωτ = 1 where the imaginary part has
a maximum.
Assuming that the relaxation process is dominated by the Brownian
relaxation, we can assign τ = τB. Fig. 2.3 illustrate the ac magnetic
susceptibility for three individual particle systems with different particle
sizes that have the Brownian relaxation as the characteristic relaxation
process. According to Eq. (2.2), the Brownian characteristic time of
these particles depends on their hydrodynamic volume. Therefore, the
particle system with greater size (volume) has a longer relaxation time.
In practice, the colloidal magnetic particles have a particle size dis-
tribution. One commonly used model for the size distribution of the
magnetic particles is the log-normal distribution:
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Figure 2.3: Normalized ac magnetic susceptibility for samples with 3 different particle sizes.
The imaginary part of the susceptibility maximizes as the frequency approaches the Brownian
relaxation frequency for each particle, ωτ = 1. Increasing the hydrodynamic diameter of the
particles (d1 > d2 > d3) shifts the relaxation dynamics to lower frequencies (f1 < f2 < f3)
and vice versa.
f(rH) =
1√
2pirH ln σ
exp[−(ln rH − ln r¯H)
2
2 ln2 σ
] (2.9)
where r¯H is the median hydrodynamic radius and σ is the standard
deviation, which defines the width of the distribution [59, 71]. Taking
the size distribution of the MNP into account, the ac susceptibility then
becomes:
χ(ω) =
∫ χ0
1 + iω(rH)
f(rH)drH (2.10)
where the f(rH)drH is the number of particles with radius between rH
and rH + drH [46]. By experimentally measuring the ac magnetic sus-
ceptibility χ(ω), it is thus possible to estimate the relaxation time and
the particle size distributions [72, 73].
2.2.2 Cole-Cole model
Dispersion of frequency-dependent ac susceptibility from the MNPs with
distribution in relaxation time obeys the following phenomenological for-
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Figure 2.4: Examples of the real (a) and imaginary (b) parts of ac magnetic susceptibility
for the Cole-Cole model Eq. (2.11). For α = 1, the solid blue curves, the Cole-Cole model
reduces to the Debye model Eq. (2.5). The red and green dashed lines represent the Cole-Cole
model with different phenomenological parameters of α = 0.9 and α = 0.5, respectively.
mula:
χ(ω) = χ∞ +
χ0 − χ∞
1 + (iωτ)α (2.11)
where τ is the relaxation time, χ∞ is the high-frequency susceptibility,
and α is the phenomenological parameter which defines the span of the
relaxation time and can assume values between 0 and 1. This equation
was developed by two brothers Kenneth and Robert Cole in 1941 [74].
The Cole-Cole model is also called the generalized Debye model and
can be regarded as a superposition of multiple Debye models with the
central relaxation time given by the inverse of the frequency of the peak
position on the imaginary part of the susceptibility. It is based on the
assumption that there is a distribution of relaxation times governing
the system dynamics [70]. This equation reduces to the Debye formula,
Eq. (2.5), for α = 1. For 0 < α < 1, the maximum value of the peak
χ′′ decreases, and the dispersion broadens. Therefore, the α parameter
represents the broadness of the relaxation time distribution, Fig. 2.4.
This broadening of distribution does not affect the frequency at which
the imaginary part maximizes but decreases its amplitude.
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2.2.3 Multimodal Cole-Cole model
If we have a MNP system that is composed of two or more MNP entities
with relaxation times of τ1, τ2, ... the total magnetization of the system
is a sum of the magnetizations from each entity. The total susceptibility
of the system is therefore, a sum of the susceptibility of each MNP entity
comprising the system and we have:
χ = χ1 + χ2 + · · ·+ χ∞ (2.12)
where χ1, χ2, ... are the susceptibilities of MNPs with relaxation times
τ1, τ2, ..., and the χ∞ is the high frequency susceptibility of the total
system. Using a Cole-Cole model to describe each magnetic entity in the
system, the total susceptibility of the MNP system can be generalized
to a superposition model expressed as:
χ(ω) = χ11 + (iωτ1)α1
+ χ21 + (iωτ2)α2
+ · · ·+ χ∞ (2.13)
where τ1, τ2, ... are the relaxation time, and α1, α2, ... are the phe-
nomenological width parameters for the 1st, 2nd, ... modes. The χ∞ is
the total high-frequency contribution in the real component of ac suscep-
tibility of the MNP ensemble. Fig. 2.5 shows the imaginary component
of ac magnetic susceptibility for a MNP system which consists of MNPs
with two size distributions with the median sizes of 100 and 300 nm, de-
scribed by Eq. (2.13). The multimodal Cole-Cole model is fitted to the
imaginary part of the ac susceptibility to extract the relaxation times
and model the ac susceptibility response. When the two relaxation times
of the two MNP entities (here in Fig. 2.5 MNPs of 100 and 300 nm) are
well separated, two distinct relaxation times can be observed. Other-
wise, the two peaks will merge into an asymmetric response curve with
a single peak value.
2.2.4 Biosensing approaches with ac magnetic susceptibility
Several different approaches have been introduced based on ac suscep-
tibility for biodetection [24]. The first approach is based on the shift
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Figure 2.5: Imaginary part of ac magnetic susceptibility versus frequency for a two-MNP
system comprising a mixture of a 100 nm and a 300 nm in size MNPs. The Cole-Cole model,
Eq. (2.11), for individual particle systems, blue and red dashed curves, and the multimodal
Cole-Cole model, Eq. (2.13), that models the bi-modal particle system, solid yellow curve,
are plotted.
in relaxation frequency of the MNP labels due to binding interaction
of the MNPs with target biomolecules. The frequency of the peak am-
plitude in the imaginary component of the ac magnetic susceptibility,
which corresponds to the MNP labels, shifts to lower frequencies when
the the hydrodynamic volumes of the MNP labels increase due to bind-
ing to the targets. Fig. 2.6 (a) illustrates the concept of the detec-
tion approach and the shift in the frequency of the imaginary part of
the ac magnetic susceptibility. The application of this method for de-
tecting biomolecules have been verified by detecting: prostate-specific
antigen (PSA) in a solution using MNP labeled with PSA specific anti-
bodies [34, 62] with typical LOD of 0.7 nM [62], biotinylated S-protein
with avidin coated MNP labels [75, 76] with experimental measurement
of 6.3µM S-protein [75], Brucella antibodies in serum samples from in-
fected cows using lipopolysaccarides functionalized MNPs with detection
limit of 0.05 µg/mL [77], target DNA molecules by hybridizing MNP
labels functionalized with target complementary oligonucleotides with
the DNA target with experimental limit of 33 pM [78]. This detection
method, however, is not very sensitive due to broad particle size dis-
tribution and the shift in the ac susceptibility responses only occurs at
high concentration of targets.
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Figure 2.6: Frequency shift and turn-off biodetection using ac magnetic susceptibility mea-
surement technique. (a) The detection signal is based on the shift in the imaginary component
of ac susceptibility due to binding reaction with target molecule. The hydrodynamic size of
the MNP labels increase upon binding with the target molecule and shifts the frequency of
the imaginary ac susceptibility response to lower frequencies. (b) In the magnetic suscep-
tibility reduction method, or turn-off detection approach, the amplitude of the ac magnetic
susceptibility signal decreases upon binding of the target analytes with MNP labels.
Another approach to detect biomolecules focuses on the reduction in
peak amplitude of the ac magnetic susceptibility of the MNP labels.
The target-label complex either has a much larger hydrodynamic size or
clusters, and therefore has its relaxation frequency well separated from
the unbound MNP labels. This causes the amplitude of the imaginary
part of the ac magnetic susceptibility at the relaxation frequency of the
free MNP labels to reduce. Fig. 2.6 (b) shows an illustration of the mag-
netic susceptibility reduction method which is also known as the turn-off
approach [79]. Target DNA molecules are detected using MNP labels
functionalized with target complementary oligonucleotides using low-T c
SQUID with LOD of 3.7 pM [78], portable ac susceptometer with LOD of
4 pM [80], and high-T c SQUID with LOD of 1 pM as we have reported in
paper II. A mixed-frequency ac magnetic susceptibility reduction (with
two ac excitation fields at two different frequencies) was used to mea-
sure avidin molecules using biotin coated MNP labels [81] and c-reactive
protein (CRP) with MNP labels functionalized with anti-CRPs [82, 83].
Nonlinear magnetization of MNP with magnetic excitation at a combi-
natorial frequencies was also used in a magnetic immunoassay to detect
Yersinia pestis and Francisella tularensis antigens, and Legionella pneu-
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mophila bacteria [84]. Although this approach of detection has higher
sensitivity to the target analyte compared to the earlier one, for low con-
centration of the target analyte the signal reduction is low and difficult
to detect. The quantification of the target analyte in this case is sensi-
tive to the disparities in the initial number of MNPs and the variations
in signal when no target is present.
An alternative way of using the ac susceptibility is to use the phase
representation of the ac magnetic susceptibility. According to Eq. 2.6,
the susceptibility can be written in terms of phase and amplitude:
χ(ω) = χ′(ω)− iχ′′(ω) = |χ|e−iθ. (2.14)
In this expression, θ is a measure of the phase angle between the external
excitation field and the magnetization of the sample. It can be defined
as an inverse tangent of the real and imaginary ac susceptibility as the
following [65]:
θ = arctan(χ
′′
χ′
). (2.15)
where χ′ and χ′′ are real and imaginary components of ac magnetic
susceptibility. CRPs in human samples are detected using this method
by forming magnetic clusters of functionalized iron oxide MNPs and
CRPs [85]. The same principle has also successfully been applied (at
frequencies below 10 Hz) in the optomagnetic measurement method [51]
for detection of DNA targets [86]. In both of these two biosensors, the
detection signal, which is the phase angle increases with increasing the
concentration of target molecules. This method is called the turn-on
detection strategy and is not limited to phase-based detection. Turn-on
detection approach is also used in the imaginary part of ac magnetic
susceptibility measurements to detect DNA targets using 40 nm MNP
labels [87].
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CHAPTER 3
Experimental methods
Biosensors are analytical devices utilizing the high sensitivity and selec-
tivity of biological sensing. They are comprised of two main components:
(I) a bioreceptor and (II) signal transduction. There is a diverse vari-
ety of biosensors combining different biological recognition elements with
different signal transduction methods. In this chapter, we describe these
two main components of our biosensor. First, we describe the basic
principles and different steps of the nucleic acid assay used to detect
the target DNA molecules. Nucleic acid assays are a group of biosensors
that adopt DNA as bioreceptor. They use a single-strand DNA which hy-
bridizes to its complementary strand with good specificity to realize the
detection of a specific DNA or RNA target. These nucleic acid-based sen-
sors can be used to detect not only pathogens, infection diseases but also
inorganic and organic molecules and even organisms [13]. Here we use
rolling circle amplification (RCA) to linearly amplify the recognized tar-
get DNA molecule, producing a rolling circle product (RCP) which has a
larger hydrodynamic volume. The RCPs are results of the biodetection,
and by labeling them with magnetic or fluorescent tags, we transduce the
biorecognition into an optical (fluorescence) or a magnetic signal. The
fluorescent-labeled RCPs are detected using nanoparticles tracking anal-
ysis (NTA) technique, basic principles of which is explained here. The
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magnetically labelled RCPs are detected using a high-T c SQUID gra-
diometer which is our main development. Sec. 3.3 describes the different
components of the magnetic sensor in details which is then followed by
calibration of the system using MNPs.
3.1 Nucleic acid assay
The genetic information encoded as a sequence of monomers in nucleic
acids, DNA and RNA, are responsible for cellular function and conse-
quently essential for all forms of life. The monomer building blocks are
nucleotides which are made of a 5-carbon sugar, a phosphate group and
a nitrogenous base. Nucleic acid diagnostics measure DNA or RNA in
order to assay a particular nucleic acid sequence. To detect low abundant
nucleic acids, numerous methods have been developed which selectively
copy a specific and pre-defined nucleic acid sequence [88, 89].
The first and most commonly used nucleic acid amplification method
is the PCR which has been broadly validated. The PCR technique relies
on thermal cycling of the reaction for replication and amplifies a specific
target DNA sequence to a large number of copies. Despite all its advan-
tages, PCR has its limitations, such as high chances of false positives
and contamination, sensitivity to specific contaminants, inhibitors, and
thermal cycling [90].
There are several alternative amplification methods to PCR that offer
potential advantages for speed, scale, cost and simplicity, e.g. LAMP [16],
LCR [17], and RCA [18]. In our bioassay, we are using the RCA tech-
nique for amplification. RCA is an isothermal process and enables enzy-
matic amplification of the probe-target complex. The biomolecular de-
tection technique utilizes a highly specific hybridization reaction between
a probe molecule and a matching target forming a circular probe-target
complex. This proves to be advantageous for genotyping or mutation de-
tection in an unrelated background. The probe-target complex can then
be amplified in order to achieve high sensitivity in a single-molecule de-
tection [36, 90].
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Figure 3.1: Illustration of (a) padlock probe recognition of target DNA, (b) ligation, (c) the
amplification of the probes by RCA.
3.1.1 Target DNA recognition and enzymatic amplification
Engineered probing molecules are used for target recognition. These
DNA molecules (padlock probes) are synthetic linear oligonucleotides,
typically consisting of 70-100 nucleotides in length [91]. Around 20 out-
ermost nucleotides at both 3′ and 5′ ends of the padlock probes are
sequences complementary to the target DNA sequence. Therefore, they
hybridize to the target DNA sequence in juxtaposition. The rest of the
sequence linking the two hybridization arms are used for detection and
identification. After the probes are hybridized to the targets, a ligase
mediated process closes the nick in between the two ends and topologi-
cally locks the padlock to the target. The ligation process is susceptible
to any mismatches at the 3′ end of the padlock probe molecule. This
allows an excellent sequence probing and detects any mutations down to
single nucleotide [92, 93].
The circularized padlocks are then amplified by the continuous pro-
gression of Φ29 polymerase around the padlock probe replicating its com-
plementary sequences. This process produces complimentary copies of
the circularized probe-target complex, joining them end-to-end within
a single DNA macromolecule [93]. This DNA molecule is also called
DNA coils, or rolling circle products (RCPs). Fig. 3.1 is a cartoon that
illustrates the different steps of the assay.
The amplification time determines the length of the RCP and one hour
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reaction time produces around 1000 complementary copies. However, the
amplification process is random and the final RCPs have a broad size
distribution [94]. RCA is a linear process and each RCP corresponds to
one single target DNA molecule. In a recent study by Kühnemund et al.,
the final concentration of the RCPs after the amplification is determined
experimentally. This study shows that the actual number of the products
is only 22.6% of the initial target DNA molecules [95]. The discrepancy
is related to the imprecise determination of the concentration by the
vendors, inefficiencies during ligation and amplification reactions. The
protocols used for the ligation and amplification processes can be found
in the Appendix A.
3.1.2 Fluorescent and magnetic labeling of RCPs
The RCPs can be analyzed by various methods including gel electrophore-
sis [96, 97], incorporation of fluorophore-conjugated nucleotide triphos-
phate (dNTP) for fluorescent microscopy and spectroscopy [98] or hy-
bridization of complementary strands with fluorescence markers, gold
nanoparticles [99], magnetic nanoparticle (MNP) [78], quantum dots [100],
etc. In this work, we detected the RCPs optically and magnetically by
addition of fluorescent or magnetic labels, respectively. The fluorescent
or magnetic labels have oligonucleotides which are complementary to
the linking part of the padlock probes. This allows them to bind to the
RCPs by base-pair hybridization. The labels, therefore, crowd around
the RCPs which then can be detected optically or magnetically.
In this work, both fluorescent-tagged detection oligonucleotides and
functionalized streptavidin-coated MNPs are used as physical labels for
optical and magnetic detection, respectively. The detection oligonu-
cleotides have a biotin molecule on the 3′ side and either Atto-488 or
6-Fam fluorescent dye on the 5′ site. The detection oligonucleotides can
be used as they are as fluorescent labels, however, the MNPs should be
functionalized with the detection oligonucleotides before hybridization
with the RCPs. The streptavidin coating of the MNPs has high affin-
ity for the biotin molecule conjugated to the detection oligonucleotide.
Therefore, the coupling of oligonucleotides to the MNPs surface makes
them functional for specific binding to the RCPs. Fig. 3.2 illustrate the
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Figure 3.2: The detection oligonucleotide for labelling of RCPs from Vibrio Cholerae DNA
target. The oligonucleotide has a biotin molecule on one side for coupling to MNPs and a
fluorescent dye on the other side for optical detection. The oligonucleotide tags are bound to
the streptavidin shell of the MNPs by high affinity and rapid biotin-streptavidin interaction.
different parts of a detection oligonucleotide. The conjugation of the
optical and magnetic labels to the RCPs is performed by adding the la-
bels to the RCP sample solution and incubating it at 55 ◦C for 20 min.
During the hybridization the sample volume is kept small in order to
increase the chance of the tags and the RCPs to meet.
3.2 Nanoparticle tracking analysis (NTA)
To detect the fluorescent-tagged RCPs, NTA is used. NTA utilizes a
laser beam to detect the light scattering or fluorescence signal from the
Brownian motion of the particles in liquid suspension in order to de-
termine the particle size distribution. A laser beam of specific wave-
length is passed into the sample chamber containing the nanoparticle
suspension with reduced profile [101]. The particles in the path of the
beam then scatter or absorb the light which is easily visible using a low
magnification microscope objective, Fig. 3.3. A complementary metal
oxide semiconductor (CMOS) camera records the particles movement in
the fields of view. A software then identifies each particle and tracks its
movements under Brownian motion on a frame by frame basis and calcu-
lates the average distances moved by individual particles. The spherical
equivalent of the particle diameter, d, is given by the Stokes-Einstein
equation:
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D = kT/3piηd (3.1)
where D is the particle’s diffusion coefficient, k is the Boltzmann con-
stant and T is the temperature. We use NanoSight LM20 (Nanosight,
Amesbury, United Kingdom) which utilizes a 488-nm laser for NTA mea-
surements. The samples are injected in the sample chamber using a ster-
ile syringe and a syringe pump. The NTA 2.0 software is then used for
capturing and analyzing the data.
Figure 3.3: Schematic illustration of NTA system. A laser beam is passed into the particle
suspension and the scatter or fluorescent light is collected using a microscope where the
particles movements are recorded by a CMOS camera.
3.3 Ac magnetic susceptibility measurement setup
Magnetic ac susceptometry is a frequency domain measurement tech-
nique and provides information regarding the relaxation time and size
distribution of the MNPs, see Sec. 2.2.1. The specific binding of the
MNPs to the RCPs changes their hydrodynamic size. According to
Eq. (2.2), this change in the hydrodynamic size affects the Brownian
relaxation time of the MNPs. We have developed a biosensor for mea-
surement of the MNPs (magnetic markers) in our bioassay using the ac
magnetic susceptibility technique. The setup consists of:
• a high-T c SQUID sensor,
• a liquid nitrogen (LN2) cryostat or a micro-cooler to maintained
SQUID sensor below its transition temperature,
• magnetic shielding or a magnetically shielded room (MSR),
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• SQUID electronics to operate the sensor,
• microfluidic chips to bring the sample solutions to the detection
areas above the SQUID sensor,
• a 3D-printed alignment frame mounted on the cryostat for control-
ling the position of the microfluidic chip above the sensor,
• a Helmholtz coil to apply homogeneous external ac magnetic field.
The measurement technique involves magnetization of MNPs by an
external ac magnetic field produced by the Helmholtz coil and measur-
ing the sample dynamic magnetic moment by the SQUID gradiometer.
The in-phase and out-of-phase components of the SQUID signal acquired
from magnetic samples are expressed as a voltage (or flux) read out from
the SQUID electronics. The voltage is directly proportional to the mag-
netic moment of the sample. Since the magnetic susceptibility is only a
calibration factor that converts the voltage to a sample magnetic moment
(and ac susceptibility by dividing magnetic moment with field amplitude
and sample volume), the voltage values are used as the sample’s mea-
sured ac magnetic susceptibility. The calibration factor can be extracted
by measuring a material with known magnetic characteristics like dys-
prosium oxide (Dy2O3) or by comparing the SQUID signal with another
already calibrated instrument (like DynoMag, RISE Acreo) measuring
the same sample.
A waveform generator (Fluke AWG-220) produces a sinusoidal wave
which is amplified using a current amplifier to drive the Helmholtz coil.
The coil can create a sinusoidal and homogeneous excitation field up
to 350 µT, which is limited by the current amplifier. The excitation
field is in the range of 0.5 Hz to 10 kHz. The SQUID signal is read
out by Magnicon SEL-1 electronics. A Stanford SR-860 lock-in ampli-
fier is used to extract the in-phase and out-of-phase components of the
SQUID gradiometer signal having the current in the Helmholtz coil as
a reference. The in-phase and out-of-phase signals are functions of real
and imaginary components of the magnetic susceptibility from the mag-
netic samples, respectively. Fig. 3.4 shows a schematic diagram of the
ac susceptibility measurement setup. To eliminate the residual coupling
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Figure 3.4: A schematic diagram of the lock-in measurement setup and a cross-section
schematic illustration of the LN2 cryostat for magnetic ac susceptibility measurements. The
function generator through a current amplifier drives the Helmholtz coil to produce homoge-
neous ac magnetic excitation field. The SQUID readout signal from the SQUID electronics
and a reference signal at excitation frequency, which is a voltage drop across a small resistor
(0.01Ω) placed in line with the Helmholtz coil, are given to the lock-in amplifier for phase
sensitive measurement. The in-phase and out-of-phase components of the signal are collected
by a computer using a program interface in MATLAB ver. R2018b (The MathWorks, Inc.,
Natick, Massachusetts, United States).
of the excitation field to the pick-up coils, a calibration measurement
is made without having any samples. This calibration is taken as the
background signal, which is subtracted from all measurements. In the
following sections, the details of different components of the ac magnetic
susceptibility measurement setup are described.
3.3.1 High-Tc SQUID gradiometer sensor
To reach a very high sensitivity to the magnetically labeled RCPs, we
need to have a sensitive magnetic sensor. The SQUID is a magnetic
flux-to-voltage transducer and is among the most sensitive magnetic field
sensors. It is made of a superconducting loop which contains one or two
Josephson junctions. Josephson junctions are active devices in supercon-
ducting electronics and consists of two weakly coupled superconducting
electrodes [102]. SQUIDs can be made using both low temperature su-
perconductor (LTS) and high temperature superconductor (HTS) ma-
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terials. The discovery of superconductivity in the yttrium barium cop-
per oxide YBa2Cu3O7−δ (YBCO) compound material with TC = 93 K
opened doors to use the low price and abundant liquid nitrogen as the
refrigerant and boosted the applications of HTS materials. It is also pos-
sible to reduce the distance between the room temperature samples and
the HTS sensors. Therefore, our magnetic biosensor uses HTS SQUID
sensors.
Fig. 3.5 (a) illustrates a dc SQUID and its typical current-voltage
characteristics in external applied magnetic flux at two extreme cases of
integer flux quantum, (n)Φ0, and half-integer flux quantum, (n+1/2)Φ0.
The magnetic flux quantum is defined by the Plank constant and the
charge of the electron and is equal to, Φ0 = h/2e = 2.068 × 10−15 Wb.
The SQUID is biased with the bias current slightly exceeding the critical
current of the SQUID where a dc voltage appears across the junctions.
The applied external flux creates a phase difference across the Josephson
junctions. The total current is the sum of the critical currents in the two
junctions. As a result, the total critical current of the SQUID depends
periodically on the applied magnetic flux. When the applied flux reaches
half a flux quantum, Φ = Φ0/2, the total critical current reaches its
minimum. As the external flux increases to an integer number of flux
quanta, the critical current reaches its maximum. The voltage drop
across the SQUID in turn swings between the two extreme cases as
a function of external flux with a period of Φ0, Fig. 3.5 (b). SQUID
is therefore a flux-to-voltage transducer and the maximum response to
a small change in the applied flux is obtained where the flux-voltage
transfer function VΦ ≡ |(∆V/∆Φext)Ib| is maximum.
There is a wide range of input circuits that can be coupled to the
SQUID for various applications. In order to measure magnetic fields, a
flux transformer pick-up loop configured as a magnetometer or gradiome-
ter is coupled to the SQUID. Both the SQUID magnetometer and gra-
diometer are only sensitive to the variation of the magnetic field rather
than measuring the absolute field strength. For our biomagnetic mea-
surements, the SQUID sensor should operate outside a MSR in a ho-
mogeneous magnetic field in the vicinity of the SQUID. Furthermore,
the first order field gradient term decays slower than the higher terms
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Figure 3.5: (a) Schematic of a dc-SQUID with two Josephson junctions interrupting the su-
perconducting ring and the current-voltage characteristics of the SQUID in a integer ((n)Φ0)
and half-integer ((n+ 1/2)Φ0) multiples of external applied flux quantum. (c) Voltage versus
applied external flux dependency of the SQUID for an applied constant bias current.
with the distance from the magnetic sample. Therefore, the first order
gradiometer layout is a more appropriate option for a sensor because it
discriminates against distant magnetic sources and allows the magnetic
field source close to the SQUID.
Two different layouts for the first order planar SQUID gradiometer
are used in our experiments. Paper II uses the SQUID gradiometer I as
shown in Fig. 3.6 (a) and Paper III and IV use the gradiometer II layout
illustrated in Fig. 3.6 (b). The differences in the two gradiometers are
minor. The baseline of the gradiometers, connecting the center of the
two superconducting pick-up loops, is 3.6 mm. The screening currents
induced by the external magnetic field in each of the two pick-up loops
of a gradiometer cancel each other in the centerline of the loop. The
SQUID is placed in the center of the middle line. The SQUID is directly
connected to the pick-up loops and therefore can sense only the differ-
ence in magnetic flux in them. In both layouts, the SQUID is made from
bicrystal grain boundary junctions in the YBCO film. The SQUID gra-
diometer sensors are fabricated in house and the fabrication technology is
comprehensively described in earlier work [103]. The SQUID is operated
in a so-called flux locked loop (FLL) due to its nonlinear voltage-flux re-
sponse. The operating of the SQUID is outside the scope of this thesis,
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Figure 3.6: The layout of two fabricated SQUID gradiometers. (a) The gradiometer I was
used in Paper II and has a 3.6 mm baseline. The widths of the pick-up loops are 400 µm.
The SQUID loop has 4 µm wide strip lines, and the length and width of the slit are 50 µm
and 3 µm, respectively. (b) The gradiometer II also has a 3.6 mm baseline and was used in
paper III & IV. The widths of the pick-up loops are 400 µm. The SQUID loop has 3 µm
wide strip lines, and the length and width of the slit are 42 µm and 3 µm, respectively.
The red and green dashed line indicates the bi-crystal grain boundary and the baseline of
the gradiometers, respectively. The grain boundary creates the Josephson junctions in the
superconducting SQUID loop.
and an interested reader is referred to the SQUID handbook [104].
3.3.2 Liquid nitrogen cryostat
To operate the SQUID gradiometer sensor, it should be cooled down be-
low the YBCO superconducting transition temperature of about 93 K.
Therefore, the SQUID gradiometer sensor should be operated inside a
LN2 cryostat or any other suitable cooler that provides operation tem-
perature below YBCO transition temperature. The lower operating tem-
perature is preferable because higher level of noise is induced close to
the transition temperature of the superconductor due to higher thermal
noise, and fluctuations in SQUID parameters. The cryostat is made in-
house from nonmagnetic materials. The sensor chip sits on a sapphire
rod in direct contact with the liquid nitrogen. The liquid nitrogen reser-
voir is made out of fiberglass and is thermally decoupled from the envi-
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Figure 3.7: A photograph of the home-built liquid nitrogen cryostat. The SQUID is located
behind the 250 µm thick sapphire window and the Helmholtz coil is aligned so that the
SQUID is at the center of the coil with highest field homogeneity.
ronment by vacuum. A 250 µm thick sapphire window on the polyvinyl
chloride (PVC) vacuum jacket separates the 77 K vacuum enclosed envi-
ronment of the SQUID sensor from the room temperature environment.
The distance from the sensor to the top of the sapphire window is less
than 1 mm to allow better coupling between the magnetic samples and
the superconducting pick-up coils of the gradiometer. A Helmholtz coil
with a radius of 15 cm is used for producing a homogeneous magnetic
field. The Helmholtz coil uses a movable frame to manually align the
external magnetic field to minimize the coupling between the excitation
field and the pick-up loops of the SQUID gradiometer. Fig. 3.7 shows
a picture of the home-built liquid nitrogen cryostat setup. A schematic
cross-section view of the cryostat is illustrated in Fig. 3.4.
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3.3.2.1 Noise properties of the SQUID sensor in liquid nitrogen cryostat
The flux noise of the SQUID gradiometers cooled down using the LN2
cryostat is measured inside the MSR. Fig. 3.8 shows the spectral density
of the flux noise, S1/2Φ of gradiometers I and II which is given by the
spectral density of the voltage noise, S1/2V , across the SQUID:
S
1/2
Φ = S
1/2
V /V
2
φ (3.2)
where the Vφ is the transfer function of the SQUID which is about 1 and
2 V/Φ0 for gradiometer I and II. The best white noise levels achieved
for gradiometer I and II are 12 µΦ0/
√
Hz and 4 µΦ0/
√
Hz, respectively.
The equivalent magnetic field noise of the SQUID gradiometer sensors
can be extracted from the flux noise density by dividing it with the
effective area, Aeff , of the gradiometer:
S
1/2
B = S
1/2
Φ /Aeff . (3.3)
The effective area of a gradiometer is difficult to calibrate experimentally,
but assuming negligible SQUID effective area it can be approximated by
Aeff ≈ Lc Ap2Lp , where Lc is the coupling inductance between the pick-up
loops and the SQUID, Ap is the effective area of the pick-up loops, and
LP is the inductance of the pick-up loops [105]. The magnetic field noise
of the gradiometer I and II are about 1 pT/
√
Hz and and the gradient
resolution is approximately: S1/2G = S
1/2
B /b = 2.8 pT/cm
√
Hz, where b
is the baseline of the gradiometer (≈ 3.6 mm for both gradiometers).
The 1/f noise, which is due to critical current fluctuations, is efficiently
suppressed by operating the SQUIDs in bias reversal mode. This is
important as the operating frequency window in our measurements is
between 1 and 3000 Hz.
3.3.3 Two stage Joule–Thomson micro-cooler
Using LN2 for cooling the SQUID sensor is an obstacle in realizing a
POC diagnostics. LN2 is not available in many places, especially re-
mote areas where POC diagnostics is needed. It also requires access
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Figure 3.8: Spectral density of magnetic flux noise of the gradiometer I (a) and gradiometer
II (b) are measured inside a MSR. The blue curve in (a) is measured using dc-bias and shows
high 1/f noise. This 1/f noise is due to critical current fluctuations and is suppressed by
using bias reversal as can be seen in the red curve.
to providers with facilities for production and delivery of the LN2, and
training of the operators for handling it. To eliminate the use of LN2
and to provide an easy operation of the SQUID sensor, we have used a
micro-cooler system based on a commercial desktop CryoLab unit from
DEMCON Kryoz (www.demcon-kryoz.nl). It uses micro electro me-
chanical systems (MEMS) based Joule-Thomson coolers. The cold stage
is made of a silicon wafer with microchannels where high-pressure gas
flows to a flow restriction where it undergoes a Joule-Thomson expan-
sion to low-pressure side and usually changes its phase to a liquid. The
liquefied gas then evaporates by absorbing heat from its surroundings,
producing low-pressure gas [106]. The CryoLab is an open-cycle system
and contains a two-stage MEMS micro-cooler utilizing a high-pressure
nitrogen gas (95 bar; ultra-high purity grade, 99.999%) from a commer-
cial gas cylinder. Fig. 3.9 (a) shows the time dependency of the cold
stage temperature when it is cooled from room temperature to the base
temperature of 78 K. It is quite fast and reaches the base temperature
of 80 K in about 30 min.
3.3.3.1 Noise properties of the sensor cooled with the micro-cooler
We have successfully operated the SQUID gradiometer for the first time
in a two-stage MEMS based micro-cooler. The magnetic flux noise of
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Figure 3.9: (a) Temperature of the cold tip of the micro-cooler as a function of time during a
cool down from ambient temperature. The tiny bump indicates the point where the pressure
regulation was switched to manual mode. (b) Spectral density of magnetic flux noise of the
SQUID gradiometer cooled with micro-cooler (solid black line) and a liquid nitrogen cryostat
(red dashed line) inside the MSR. Adapted form paper I.
the SQUID gradiometer cooled down with the micro-cooler is measured
inside the MSR. Fig. 3.9 (b) shows the spectral density of the magnetic
flux noise of the SQUID gradiometer. The micro-cooler was powered
from an external dc power supply to eliminate various power-line cycle
noise contributions in the vicinity of the SQUID sensor. The spectral
noise density of the same sensor which was cooled in the LN2 cryostat is
also plotted in the same figure for comparison. The low-frequency peaks
below 20 Hz are due to either electromagnetic noise from the membrane
pump or vibrations in the nitrogen gas flow through the micro-cooler.
The higher white noise level of the sensor in the micro-cooler may be
due to the combination of errors in the calibration of the SQUID trans-
fer function, different configurations in the feedback circuits and the
higher resistance of the connecting manganin wires (all SQUID connec-
tion wires are from copper in the LN2 cryostat). The higher resistance
of the connecting wires contributes to the total noise of the SQUID.
Overall, the magnetic flux noise of the SQUID gradiometer is largely
unaffected by the micro-cooler setup. This is promising for the stable
operation of SQUID sensor without using LN2. Further optimization is
required to implement the micro-cooler in real field applications. This
includes the elimination of additional wire resistance and the noise orig-
inating from the miniature membrane pump in the control unit by intro-
ducing a proper magnetic shielding between the pump and the sensor.
The system should also be developed as a closed-cycle unit to reuse the
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low-pressure gas and eliminate the supply of external gas cylinders.
3.3.3.2 Ac susceptibility measurements in the micro-cooler
We have also performed ac susceptibility measurement on MNPs using
a SQUID gradiometer sensor cooled in the micro-cooler. Fig. 3.10 (a)
is the complete setup with the home-built poly(ethylene terephthalate)
(PET) vacuum housing and the Helmholtz coil for magnetic excita-
tion. The Helmholtz coil is mounted on an alignment frame to min-
imize the coupling of the excitation field into the SQUID gradiometer
loops. Fig. 3.10 (b) shows the real and imaginary components of ac mag-
netic susceptibility measurement from 100 nm streptavidin-coated MNP
(1 mg/mL). During these measurements, the setup was cooled down and
operated outside the MSR. These results show the feasibility of operat-
ing the SQUID without LN2 in an unshielded environment and demon-
strates the possibility of ac magnetic susceptibility measurements on the
micro-cooler device. There are, however, some drawbacks that require
modifications of the system. The SQUID sensor in the micro-cooler has
higher white noise levels than in the LN2 cryostat, Fig. 3.9 (b). This af-
fects the sensitivity of the ac magnetic measurements in the micro-cooler
compared to the LN2 cryostat. The cold fingers are gold plated, and the
ac excitation magnetic field from the Helmholtz coil induces eddy cur-
rents which are picked up by the sensor. The SQUID gradiometer should
also be shielded as environmental magnetic noise disturbs the operation
of the SQUID and, causes trapped flux inside the superconducting loops
which requires warming up the SQUID sensor.
3.3.4 Microfluidics
Gradiometers are not sensitive to the distant sources. To measure the
magnetic signals from the MNP samples, they should be located close to
the gradiometer sensor. The implementation of the microfluidic channels
in our biosensor provides control of the volume and geometry of the
MNP solution. Microfluidics also facilitate the sample handling and later
implementation of lab-on-a-chip technology. We ensure a maximized
coupling by minimizing the distance between the microfluidic channel
and the pick-up loops of the gradiometer sensor. This allows higher
signal levels from lower MNP concentrations and therefore, increases
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Figure 3.10: (a) A photograph of the complete system with its PET vacuum chamber
and Helmholtz coil for magnetic excitation. The vacuum chamber has sapphire window of
0.25 mm thickness that provides access to the sensor and separates the cold stage from the
room temperature environment. (b) Ac magnetic susceptibility of 100 nm MNP (1 mg/mL)
versus the excitation frequency measured by SQUID gradiometer cooled down using the two
stage micro-cooler.
the sensitivity of the whole assay to the RCPs. Appropriate alignment
of the microfluidic channel with respect to the gradiometer sensor is
also crucial for achieving maximum sensitivity to the MNP material.
Therefore, a 3D-printed alignment frame which allows moving of the
microfluidic chip in the X-Y plane of the sapphire window above the
SQUID is mounted on the cryostat. A peristaltic pump connected to the
sample vial allows pumping a small sample volume to the microfluidic
channel for measurement.
Different materials can be used to fabricate microfluidic devices such
as silicon, glass, and poly(dimethylsiloxane) (PDMS). We have chosen
PDMS for our microfluidic chip for its fast, easy and cost-effective fabri-
cation process. It is non-toxic, biocompatible, durable, flexible, and easy
to handle, which makes it a great candidate for future POC develop-
ments [107]. PDMS devices are fabricated using soft lithography [108].
There are different methods to fabricate the master mold for casting
replicas, such as photolithography, wet etching, wet/dry silicon etching,
etc. Since the microfluidic devices being used here are rather simple and
have large features, precision machining has been used to fabricate the
master molds for the microfluidic devices. The main advantage of this
technique is the fast transfer of a computer aided design (CAD) into a
finished device. The structure of the channel is precisely machined into a
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Figure 3.11: (a) The dimensions of the microfluidic channel, and photographs of completed
(b) single channel, and (c) double-channel PDMS chips enclosed by bonding a 100 µm thin
PDMS cap layer.
master aluminum piece, and many copies of the device are made from the
same mold with good accuracy using the elastomer PDMS. Fig. 3.11 (a)
shows the dimensions of the microchannel with 1×1 mm2 channel cross-
section and photographs (b) and (c) of the two completely fabricated
chips used in our experiments with single and double channels.
The molding creates a PDMS replica with only three walls. Therefore,
the channel has to be sealed separately. Since the magnetic samples
should be as close to the sensor as possible, a thin layer of PDMS is
used. A 100 µm thin layer is spin-coated on a silicon wafer and heat
cured. Then the capping layer and the PDMS replica are put together
to seal the channel since surface adhesion of the PDMS is sufficient to
create a good contact. To make sure we have a tightly enclosed channel
that does not leak under pressure, the two surfaces of the PDMS and
the capping layers are primed in oxygen plasma before they are brought
into contact. This process increases the bonding strength and can lead
to a permanent bond between the two by forming covalent bonds [109].
3.4 Calibrating the setup with MNPs
Here, we present the ac magnetic susceptibility measurement of the
100 nm MNPs. The results are presented according to the kind of mi-
crofluidic chip used (single channel or double channel) and the alignment
of the SQUID gradiometer in the magnetic field (parallel or perpendicu-
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lar to the baseline of the gradiometer). All the following measurements
are carried out using the LN2 cryostat.
3.4.1 Single channel microfluidics
In this configuration, the baseline of the gradiometer is in-plane and
parallel to the external magnetic field line. The single-channel microflu-
idic chip which carries the MNPs has the maximum coupling to the two
pick-up loops of the gradiometer if it is placed above the middle line of
the gradiometer. Fig. 3.12 (a) is a schematic illustration of this configu-
ration and shows the evaluated magnetic flux threading the gradiometer
loops using a simple model considering the MNPs as point-sources and
randomly distributing them in the volume of the microfluidic chip [110].
Aligning the channel with the upper or the lower lines of the gradiometer
(parallel to the middle line of the gradiometer) would result in coupling
of magnetic flux from the sample to only one of the two pick-up loops.
Fig. 3.12 (b) shows a photograph of the single-channel microfluidic chip
aligned above the middle line of the gradiometer which gives the max-
imum coupling between the MNP sample in the microfluidic chip and
the gradiometer sensor.
The in-phase and out-of-phase components of the SQUID signal ac-
quired from streptavidin-coated MNPs of various concentrations diluted
in PBS versus the excitation field frequency are reported in Paper II.
The samples are measured at the maximum excitation field strengths
of 40 µT. The imaginary part of the ac magnetic susceptibility has its
peak amplitude at the Brownian relaxation frequency at around 80 Hz.
The amplitude of both real and imaginary parts of the ac susceptibil-
ity decreases with decreasing the concentration of MNPs. There is no
frequency shift in the peak position of the imaginary part due to mag-
netic field strength or MNP concentration. This indicates that we are
in the low field region, and there are no magnetic interactions between
MNPs [111].
To extract the MNP sensitivity, the peak amplitude of the imaginary
component of the susceptibility for different concentrations of the MNP
is plotted against the number of particles. The number of MNPs in
each concentration is estimated from the known number of particles per
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Figure 3.12: (a) A schematic illustration of the channel alignment with respect to the SQUID
gradiometer sensor and simulation of the normalized absolute total magnetic flux threading
the gradiometer loops. The channel has the cross-section of 1× 1 mm2 and length of 3 mm
in dimensions and particles are randomly distributed in its volume. The center of the defined
channel sweeps the x-y plane of the gradiometer at a constant distance of 1.1 mm and the
resulting flux threading the gradiometer loops at each point is evaluated and normalized. (b)
A photograph of the aligned channel on the gradiometer sensor. The field line is in-plane and
parallel to the baseline of the gradiometer. As indicated by the simulations, the maximum
signal is realized by aligning the microchannel above the centerline of the gradiometer in this
configuration. Adapted form paper II.
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unit volume which according to the datasheet of the MNP system is
6.0× 1012 particles per ml in a 10 mg/ml concentration. Fig. 3.13 shows
the linear relation between the amplitudes of the peak imaginary com-
ponent and the number of MNPs measured at the magnetic strength of
40 µT and 250 µT. The vertical axis corresponds to the SQUID output
signal in the units of magnetic flux quanta. The extrapolation of the
linear dependence to the measured noise floor of the SQUID gives the
estimation of the theoretical magnetic content sensitivity of our system.
For gradiometer I the white noise is 1.2× 10−5 Φ0/√Hz and the corre-
sponding magnetic content sensitivity of this sensor at excitation field
strength of 40 µT is 1.5 × 106 MNPs/√Hz or 4.3 × 10−10 emu/√Hz
in magnetic moment (1 emu = 10−3 Am2). This is equivalent to 2.5 ng
of MNP. For the excitation field strength of 250 µT, the magnetic con-
tent sensitivity is 1.2 × 105 MNPs/√Hz or 2.15 × 10−10 emu/√Hz in
magnetic moment. This is equivalent to 0.25 ng of MNP, c.f. Fig. 3.13.
This value is an important figure of merit as it determines the sen-
sitivity of the magnetic sensor. These are excellent values in terms
of magnetic moment sensitivity compared to other commercial avail-
able systems such as vibration-sample magnetometers (LakeShore Cry-
otronics) with 150× 10−10 emu/√Hz and DynoMag (RISE Acreo) with
80× 10−10 emu/√Hz.
Increasing the strength of the magnetic field increases the magnetiza-
tion of the MNPs and results in higher signals from the samples. There-
fore, the sensitivity of the sensor to the magnetic material increases. At
high strength of the magnetic field the precise alignment of the SQUID
gradiometer in the field becomes crucial as any misalignment would re-
sults in large unwanted coupling of the excitation field into the pick-up
loops of the gradiometer. The strength of the field should be chosen so
that it is well below the saturation magnetization of the MNP system.
It is necessary to ensure the linear dependency of the magnetization
of the MNP system as a function of the excitation field. The intrin-
sic saturation magnetization of the 100 nm BNF starch MNP system is
370 kA/m (0.46 T) with linear field range of ±1 kA/m (±1 mT) [48],
which are well above the highest amplitude of the magnetic excitation
field applied here (250 µT).
43
3. Experimental methods
Figure 3.13: The peak amplitude of the imaginary component of the ac magnetic suscep-
tibility signal at around 80 Hz as a function of number of MNPs at maximum excitation
field amplitudes of 40 and 250 µT. The dashed line is a linear curve fitted to the data with
a regression coefficient of 0.99. The yellow and purple dash-dotted lines correspond to the
SNRs of 1 and 10 in gradiometer I.
3.4.2 Differential ac susceptibility
When the field lines are aligned in-plane and perpendicular to the base-
line of the SQUID gradiometer, the maximum coupling of the stray field
from the MNPs to the gradiometer loops is achieved by placing the
microfluidic chip with the MNP system under investigation on the side-
lines of the gradiometer which are parallel to the baseline, Fig. 3.14.
In this geometry, the screening current produced by magnetic flux from
the magnetic fluids in a single channel chip is subtracted in the mid-
dle line of the gradiometer where SQUID sensor is situated. Since the
gradiometer subtracts the signals from its two pick-up loops, using the
single-channel microfluidic will give zero signal. In this case, the double-
channel microfluidic chip, which has two independent microfluidic chan-
nels integrated into a single PDMS chip, is used for sample handling.
The channels are aligned parallel to the baseline above one of the two
sidelines of the gradiometer loop in a way that the PDMS wall that
separates the two channels is centered parallel to the middle line of the
gradiometer sensor, Fig. 3.14. In this configuration, the stray fields from
the MNP sample in each channel is only coupled to one of the two loops
of the gradiometer.
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Figure 3.14: (a) Schematic illustration of the configuration of the two microfluidic channels
above a 1st order planar gradiometer SQUID sensor. An ac magnetic excitation field (H)
is applied to the channels, in-plane with the sensor chip and perpendicular to the baseline
so that the SQUID is insensitive to it. In this configuration, the magnetic fluxes produced
by the MNPs in each channel is only coupled to one of the individual pick-up loops of the
gradiometer. (b) A top view photograph of the microfluidic chip aligned above the SQUID
sensor; the dashed blue line indicates the SQUID gradiometer and the channels are highlighted
in yellow and green. Adapted from paper III.
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Fig. 3.15 (a) shows the real and imaginary components of the ac sus-
ceptibility from 100 nm particle size MNP samples filling either Ch. 1 or
Ch. 2 of the PDMS chip. The measurements are carried out when the
channels are already filled with individual samples, and the sample so-
lutions are not flowing. Since each channel is coupled to only one single
pick-up loop of the gradiometer, the magnetic ac susceptibility signals
from Ch. 1 is opposite in sign compared to that of Ch. 2. The opposite
signs of the signals from Ch. 1 and Ch. 2 makes it possible to perform
differential ac susceptibility measurements between the two individual
samples in Ch. 1 and Ch. 2. In this configuration, the differential read-
out is capable of canceling signals from two identical magnetic samples
filled in both channels. The blue circles in Fig. 3.15 (a) shows the mag-
netic ac susceptibility responses from the 100 nm MNPs filling both
channels. The response signal is approximately zero and matches well
with the manually subtracted signals from the individually-filled chan-
nels. Fig. 3.15 (b) shows the differential measurement and the manually
subtracted ac susceptibility signals from individual channels and indi-
cates lower errors in the differential measurement. The similarity of the
two ac susceptibility responses shows that the measured ac susceptibil-
ity signal is a linear superposition of the positive and negative signals
from Ch. 1 and 2. When measuring two different samples filling Ch. 1
and 2, the expected result is proportional to the relative difference in
the ac susceptibility of the two samples which could, for example, be
a result of a relative difference in the particle size distributions and/or
magnetic particle concentration. The differential signal is less than 1% of
the amplitude of the signals from the individual channels. The standard
deviations in the differential measurement signals are smaller compared
with manually subtracted signals from individual channels and therefore
gives a higher SNR.
In the next step, we calibrate the magnetic sensitivity of our readout
system by measuring different concentrations of MNPs in one channel,
while a control sample with a fixed MNP concentration is present in the
other. The concentration of the control sample in Ch. 1 is 250 µg/mL,
while test samples in Ch. 2 contain MNPs with concentrations ranging
from 1 to 250 µg/mL. The results of the differential ac susceptibility
for different concentration of MNPs in the test samples are reported
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Figure 3.15: (a) The real and imaginary components of the ac magnetic susceptibility versus
the frequency of the magnetic excitation field from 250 µg/mL MNP samples filling: only
Ch. 1 (green triangles), only Ch. 2 (yellow triangles), and both channels (blue circles). The
magnetic ac susceptibility signals from ch. 1 are opposite in sign compared to that of Ch. 2
due to the differential measurement setup. (b) The measured imaginary component of ac
magnetic susceptibility, when both channels are filled, is plotted together with the sum of
the signals from the individual channels shown in part (a). This magnetic ac susceptibility
signal is considered the zero signal of the system and is ≈ 100 times lower in magnitude
compared to the individual signals in Ch. 1 or Ch. 2. The summation of the magnetic ac
susceptibility signals from the individual channels results in the same response as obtained
from the measurement. Adapted from paper III.
in paper III. When the particle concentrations in the two channels are
equal (CCh.1 − CCh.2 = 0), even if the particle concentration in each
channel is rather high, the differential susceptibility measurement gives
a zero-response signal.
On the other hand, when the concentration of the test sample becomes
significantly small as compared to that of the control sample (i.e., when
CCh.1 − CCh.2 ≈ CCh.1), the susceptibility signal saturates to that of the
control sample. This saturation can be avoided by further increasing the
concentration of the control sample. This would also extend the dynamic
range of the differential readout. Therefore, the differential readout is
highly sensitive to small differences between magnetic samples in the two
channels. This is crucial for the realization of homogeneous magnetic
assays that aim to have high dynamic range and at the same time detect
low concentrations of target molecules .
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Figure 3.16: The amplitude of the imaginary component of the differential ac susceptibility
peak at 100 Hz versus the difference in the concentration of MNPs in the two channels. When
the difference in the two concentrations is large, the background magnetic signal makes it
difficult to distinguish small differences in the test sample, and the imaginary susceptibility
saturates to that of the control sample signal amplitude. The blue line indicates the linear
range of operation and has a regression coefficient of 0.99 (excluding the zero-response and
the saturation values). Adapted from paper III.
Fig. 3.16 shows the imaginary part of the differential ac susceptibility
at the peak-amplitude frequency as a function of the difference in the
MNPs concentrations in the two channels. Using this calibration curve,
we can calculate the difference between the concentrations of MNPs in
the two samples, assuming they have the same particle size distribution.
The differential sensor signal is a linear function of the difference in the
concentrations in the two channels. For samples with different particle
size distributions, however, the full frequency response should be mea-
sured to obtain information about the difference in size distributions
between the two samples.
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CHAPTER 4
Quantification of rolling circle
products (RCPs)
In this chapter, we quantify the RCPs by labeling them with MNP and
measuring the ac magnetic susceptibility using the measurement setup
described in the previous chapter. In the following experiments, plain
particles (with no surface functionalization) and streptavidin-coated multi-
core MNPs of 100 nm in size are used. The streptavidin-coated MNPs
are functionalized with oligonucleotides by forming a streptavidin-biotin
bond, and they are used for specific binding to our target analytes,
namely the RCPs, See Appendix A. Several methods were introduced
in Sec. 2.2.4 for quantification of target molecules using ac magnetic
susceptibility measurements. First, we present and discuss the results
for the turn-off detection approach, which are published in paper II.
Then we focus on the turn-on detection of RCPs using the differential
ac susceptibility measurement technique we have developed and was in-
troduced in Sec. 3.4.2.
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4.1 Turn-off detection of RCPs
To detect the final products of the RCA process (i.e., RCPs) they are
magnetically labeled by functionalized MNPs of 100 nm in particle size,
see Appendix A. To quantify the RCPs using magnetic reduction tech-
nique, two measurements are necessary: a reference measurement and
a positive test measurement. The detection signal appears due to the
presence of the target analyte (RCPs) in the positive test sample. This
signal is a reduction in the peak amplitude of the imaginary component
of ac susceptibility (compared to the reference signal) at a particular fre-
quency. The ac magnetic susceptibility of the MNP labels reduces due to
binding with the target analytes (i.e., RCPs), which are volume amplified
for 60 min during the RCA process and have quite large hydrodynamic
sizes. The reduction is either due to the increase of hydrodynamic size
or clustering of a fraction of MNPs that are bound to the RCPs. This
will, in both cases, separate the Brownian relaxation frequency of these
formed complexes far away from the unbound MNPs.
A magnetic biosensor with high sensitivity and specificity requires a
colloidally stable MNP system. The colloidal stability is particularly
necessary and essential in the turn-off detection because fluctuations in
the reference signal could impede the sensitivity of the biosensor or cause
a false interpretation of the detection signal. While the particle system
may be stable in its initial concentration and form, handling them using
the microfluidic chips can affect the stability of the MNPs and induce
signal variations. Therefore, we first investigate the colloidal stability
of our MNPs before using them as labels for detection of RCPs. After
establishing the colloidal stability of the MNP labels in the microfluidic
channels, we quantify the RCPs using the turn-off detection approach.
4.1.1 Stability of MNPs in microfluidic channel
Measurements of the plain MNP (with no functional coating) in the
microfluidic channel show that the particle system is quite stable and
has no loss of signal over time or upon multiple filling and flushing of
the microfluidic channel. The streptavidin-coated and oligonucleotide
functionalized MNPs, on the other hand, show a loss of signal over time
when they are measured inside the microfluidic channel. This loss of
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signal might have different reasons, for instance agglomeration of the
particles, sedimentation of the particles inside the channel, or binding of
the MNPs to the surface of the PDMS channel. Since the reduction in
the imaginary component of the ac susceptibility is taken as the detection
signal when detecting the target analyte, any instability in the colloidal
solution would cause an error in the measurement, particularly at low
target concentrations.
In order to study the stability of the samples, we have measured the
ac susceptibility of the streptavidin-coated MNPs with 100 nm median
size and 1.0 mg/mL concentration inside the microchannel. Upon dif-
ferent fillings, the results showed no shift in the peak frequency of the
imaginary component or broadening of the signal. Therefore, the hy-
drodynamic size of the MNPs did not change in the measurements time
window. There is, however, some signal loss. To see the dynamical
behavior of this signal loss, the real and imaginary parts of the ac sus-
ceptibility at a frequency close to the peak amplitude of the imaginary
part were measured for 12 min. The data points were taken every second
at around 63 Hz and are plotted against time in Fig. 4.1. Both com-
ponents of the ac susceptibility show a continuous decrease with time
for the streptavidin-coated MNPs. This loss of signal is more substan-
tial and easily visible in measurements of multiple fillings of the same
sample in the microfluidic channel as shown in Fig. 4.1 (b). In this ex-
periment, the 100 nm streptavidin-coated MNPs in PBS buffer solution
show a significant loss of signal after each refill. This constant decrease
in signal with time is an issue that needs to be addressed if the particle
system is to be used in the microfluidic channels. This also indicates
that our measurement setup is sensitive to the MNP probe stability.
Slopes of the lines in Fig. 4.1 (a) define the rates at which the real
and imaginary ac susceptibility decrease over time. For the streptavidin-
coated MNPs in PBS, the real and imaginary components decrease at a
rate of -1.12 µV/s and -0.75 µV/s, respectively. In other words, it takes
2.5 and 3 min for the real and imaginary components of the ac suscep-
tibility to lose 1% of the original signal amplitude, respectively. The
signal loss can be attributed to the streptavidin coating of the 100 nm
MNPs. Streptavidin tends to bind to the surface of the PDMS channel
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Figure 4.1: (a) The real and imaginary ac susceptibility as a function of time at a constant
frequency of 63 Hz for streptavidin-coated MNPs (median size of 100 nm) in PBS. The sample
was resting inside the channel during the whole measurement time. (b) Multiple filling of
the same sample in the microfluidic channel and measurement of ac susceptibility shows that
each time the sample is removed from the channel and filled back the signal levels drop
substantially compared to the first fill.
[112] that results in the loss of the signal. This loss is at a much higher
rate compared to the plain MNPs. The slope for both the real and imag-
inary component of the ac susceptibility from the plain MNPs is around
90 nV/s and positive. At this rate of change, it takes roughly 40 hours
to affect the signal amplitude by 1%. We attribute this signal change to
the shift in the calibration (background signal) in our setup.
One possible solution is to coat the microfluidic channel with biocom-
patible materials such as poly(ethylene oxide) (PEO) and poly(ethylene
glycol) (PEG) to avoid nonspecific binding of the streptavidin-coated
MNPs to the surface [113]. These processes are short term solutions and
complicate the fabrication of the microfluidic chips. A simpler solution
is to add polysorbate 20 (Tween-20) to the buffer solutions (i.e., PBS).
Tween-20 is a non-ionic surfactant with a hydrophobic (the hydrocar-
bon chains) and hydrophilic (ethylene oxide units) functional groups.
Adding the Tween-20 to the buffers at dilution of 0.05-0.5% helps to
prevent nonspecific binding of the MNP to the walls and decreases the
surface tension.
Fig. 4.2 (a) shows the time dependence of the real and imaginary ac
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Figure 4.2: (a) Ac susceptibility measurement of 100 nm streptavidin-coated MNPs in only
PBS buffer solution including 0.05% Tween-20 shows a slower rate in the drop of the signal
amplitudes in the both components of the ac susceptibility signal. (b) Two consequent mag-
netic ac susceptibility measurements of the same sample in the microfluidic channel shows
not drop in the ac susceptibility measurement after the refilling. The addition of 0.05%
Tween-20 in the PBS buffer solution decreases the interaction of the MNP with the tubes
and microchannel and loss of material.
susceptibility as a function of time at a constant frequency of 63 Hz for
streptavidin-coated MNPs in PBS solution containing 0.05% Tween-20
in dilution. The real and imaginary components decrease at slower rates
of -0.63 µV/s and -0.14 µV/s (compared to MNP dilutions in only PBS,
Fig. 4.1), respectively. It therefore, takes at least 30 min to lose 1% of
the imaginary component original signal amplitude. Fig. 4.2 (b) shows
the positive effect of using Tween-20 in the buffer solution in multiple
fillings of the same magnetic sample in the microchannel. The MNP in
the PBS buffer containing 0.05% Tween-20 dilution shows no change in
its peak amplitude due to refilling of the microfluidic channel. The same
behavior is observed for streptavidin-coated MNPs with oligonucleotide
tags. The addition of the Tween-20 provides us with a colloidally stable
MNP system that is appropriate for turn-off/on detection of RCPs.
4.1.2 Measurement of RCPs
The RCPs of synthesized Vibrio Cholerae targets used in the following
measurements are products of 60 min RCA amplification time, Sec. 3.1.
The RCPs are labelled with 100 nm MNPs and different dilutions of
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RCPs are prepared as positive test samples. The positive test samples
contain RCPs ranging from 0 to 30 pM (picomole/L) and are measured
in the frequency range of 1 to 3000 Hz. The results are reported in
paper II. The negative control (NC) sample contains only MNP labels
with mass concentration of 50 µg/mL (50 pM), and zero concentration
(0 pM) of RCA. The imaginary ac susceptibility component for the NC
sample reaches a maximum at around 63 Hz. The reduction in the
peak amplitudes of the imaginary parts from the positive test samples
compared to the amplitude of the NC sample is the detection signal in
the turn-off detection scheme, c.f. Fig. 4.3. Due to large hydrodynamic
volume of the RCPs, the MNP-RCP complex has its Brownian relaxation
frequency at very low frequencies. Since the MNP are hybridized into
the RCPs in positive test samples, the peak amplitude at the Brownian
relaxation frequency of the free MNP is lower than in the NC sample
without any RCPs. The amplitude of this signal reduction is directly
related to the number of RCPs in the positive test sample.
We can also estimate the number of MNPs bound to each RCP in
the positive test sample. Assuming constant effective particle magnetic
moment, the peak amplitude of the imaginary component of ac sus-
ceptibility is proportional to the concentration of the MNPs [48], See
Fig. 3.13. Thus, the signal drop at each concentration of RCP repre-
sents the number of MNPs bound to the RCPs in that test sample. We
know the concentration of the RCPs in each test sample, CRCP , and the
initial concentration of the MNPs, CNC . The estimated the number of
MNPs per RCP, g, at each concentration of the test sample is therefore
given by:
g = C
bound
MNP
CRCP
= (χ
′′
NC − χ′′C)
χ′′NC
× CNC
CRCP
(4.1)
where CboundMNP is the concentration of the bound MNPs, χ′′C is the peak
amplitude of the imaginary susceptibility of test sample of concentration
C, and χ′′NC is the peak amplitude of the imaginary susceptibility of the
NC sample. We observe that g decreases from 3.6 to 1.3 as the RCP
concentrations in the test sample increases from 1 to 30 pM. On average
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we estimate 2 MNPs per RCPs which is close to what has been reported
earlier using the DynoMag system [114] and transmission electron mi-
croscopy (TEM) for 130 nm MNPs [115]. We attribute the higher value
of g at lower RCP concentration to the higher number of available MNPs
in the test sample; 50 MNPs per RCP at 1 pM to 1.6 MNPs per RCP
at 30 pM.
Figure 4.3: (a) The imaginary parts of the ac susceptibility as a function of excitation
frequency for different concentrations of RCPs ranging from 0 (NC) to 30 pM in a total volume
of 3 µL. The drop in the amplitude of both real and imaginary components of the susceptibility
indicates the increase in the number of RCPs and fewer numbers of unbound MNPs in the
solution. The red arrow shows a raise in the low frequency tail of the response with increasing
RCP concentration. (b) The extinction signal (χ′′NC − χ′′C) for different concentrations of
the RCPs at the peak frequency of 63 Hz as a function of the number of RCPs in each
corresponding concentration. The linear extrapolation gives 1.0× 105 RCPs as a theoretical
limit of detection in a 3 µL sample volume at SNR = 1. Adapted from paper II.
The amplitudes of both the real part and the imaginary part continu-
ously decrease with increasing RCP concentration. This decrease is due
to binding of MNPs to RCPs and reduction of the number of free un-
bound MNPs in the solution as the RCP concentration increases. The
60 min amplification time is expected to result in rather large RCPs, typ-
ically 1000 padlock probe copies with about 1 µm final size. Therefore,
the effective hydrodynamic volume of the MNP-RCP complex is also
large and the corresponding Brownian relaxation frequency decreases
well below 10 Hz (the Brownian relaxation frequency of the 1 µm RCA
coils is about 0.4 Hz). However, It should be noted that the NTA mea-
surements show that the RCPs tend to have a broader size distribution
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with increasing amplification time. Furthermore, the sizes of the RCPs
depend also highly on the ionic strength of the buffer solution (this is
discussed more in paper IV). The increase in the imaginary part of the
magnetic susceptibility signal below 10 Hz may be due to the appear-
ance of a low-frequency peak, the red arrow in Fig. 4.3 (a). The low
frequency peak is more pronounced for higher concentrations of RCA
coils due to the greater ratio of MNP-RCP complexes to free MNPs.
The turn-off detection signal, which is the extinction signal χ′′NC − χ′′C ,
at 63 Hz is plotted against the number of RCPs in Fig. 4.3 (b). The
sensor signal is proportional to the RCP concentration (ranging from 1
to 30 pM), with experimental LOD of 1 pM. Extrapolating the linear
dependence of extinction to the noise floor of the sensor corresponds to
an estimated theoretical LOD of about 1.0×105 RCPs corresponding to
66 fM. The reported values assumes 100% success rate for the amplifica-
tion process which has been shown to be about 22.6% [95]. This means
the experimental LOD is nearly 5 times better than the reported values.
4.1.3 Comparison with other state-of-the-art biosensor meth-
ods
The commercial SQUID magnetometer (QD MPMS XL, Quantum De-
sign) was initially used to measure the magnetic properties of the MNP
labels and their binding reactions with RCPs implementing the turn-off
detection approach [78]. Using RCA technique for amplification of target
DNA molecule, the biosensor based on this magnetometer has achieved
LOD of around 3.7 pM [78, 87]. This commercial system, however,
is quite bulky, very expensive, and requires extensive magnetic shield-
ing and cooling down to liquid helium temperature. Other magnetic
sensor systems have also been used since for detection of magnetically
labeled RCPs. Examples of such systems are commercial DynoMag sys-
tem based on induction coils [114, 116], optomagnetic sensor based on
blue-ray optical pick-up unit [117, 51, 118], anisotropic magnetoresis-
tance sensor [119], and electron paramagnetic resonance [120]. Table 4.1
lists these biosensors and summarizes their performance for compari-
son. These systems have contributed to improving the performance of
RCA based nucleic acid biosensors in terms of detection limit, operat-
ing temperature, magnetic shielding, price and compatibility for POC
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diagnostics.
Although much effort is devoted to improving the sensitivity of these
magnetic biosensors, the magnetic background signal from the unbound
MNP in the solution is one of the main obstacles to reaching lower lim-
its of detection. Using the turn-off detection approach, there are two
possible ways to increase the LOD. One is implementing a washing step
to remove the excess unbound MNP labels and another is decreasing
the number of MNPs in the solution to increase the fraction of bound
MNP labels at low RCP concentration. The former is not desirable as it
complicates the assay process and is a step away from mix and measure
concept in homogeneous assays. On the other hand, increasing the frac-
tion bound by using a low concentration of MNP probes would extend
the LOD. The fraction bound is an essential parameter in any biosensor.
In MNP based biosensor, the fraction bound is the ratio of the target
bound MNPs, Nbound, to the total number of MNP probes, Ntotal, in the
solution and is proportional to the sensor signal:
fb = Nbound
Ntotal
∝ signal. (4.2)
The fraction bound for a NC sample is zero, as there is no target for
the MNPs to bind. At very high concentration of the target, where all
the MNP probes are bound with the target, the fraction bound reaches
100% and the sensor is fully saturated. In order to detect a particular
concentration of the target, the number of MNPs should be chosen in
a way that a measurable fraction of the total MNP probes are bound.
For instance, Tian et al. has reported 780 fM LOD for RCPs using
5 µg/mL MNP probes in the turn-off detection strategy [118]. This is
15 times better LOD compared to the previous experiments in the same
setup using 100 µg/mL of MNP probes [51]. Such an improvement in the
LOD is an inherent result of 20 times decrease in the MNP concentration
(total number of labels) which has increased the fraction bound at the
reported target concentration. This improvement, however, comes at the
price of limited dynamic range, and slower binding dynamics of MNP
labels with the RCPs, which could result in longer total testing time for
the biosensor.
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The modification of the DynoMag system to include sample tubes and
a peristaltic pump system instead of the vials and stepper motors have
decreased the distance between the sample and pick-up coils and pro-
vided better control over small sample volumes. The results of magnetic
ac susceptibility measurement of RCPs in turn-off approach using this
method is presented in paper V, and the system shows improved LOD
compared to the commercially available DynoMag system. There are,
however, possibilities of improving the detection limits and performance
of our systems or generally many of these magnetic biosensors which
use the same principle of operation. Using more optimal MNP systems
with magnetic materials other than iron-oxide that would have a higher
magnetic moment to label the RCPs would improve the limit of detec-
tion of the systems. For instance, cobalt particles have at least 2 times
higher magnetization compared to the MNPs used in our experiments
and would give twice higher signals [121]. The assay can also be modified
to increase the number of MNPs binding to each RCP by optimizing the
salt concentration in the buffer solution for opening the RCP which is
a large DNA strand folding on itself. One can also use DNA templates
during the RCA in order to impose topological strain on the RCPs and
avoid folding of the DNA macromolecules. This would provide access to
the binding sites which may not be otherwise reachable inside the RCP
folded coil by the MNPs. Magnetic incubation during the hybridization
process has been shown to improve the binding kinetics [122] which could
also be used to decrease the total assay time.
The sensitivity of the turn-off approach depends strongly on the in-
accuracies in the initial concentration of the MNP labels, the precision
of measuring the reference signal, and the stability of the MNP sys-
tem. The first two factors are particularly important because the sensor
should resolve a small reduction in an already existing significant signal,
especially when measuring low concentrations of the RCPs (target ana-
lyte). In this scenario, the SNR is rather small, and one has to reduce
the concentration of the MNP labels to reach a more considerable drop
in the reference signal. It is also possible to correct the signal levels to
the initial concentration of the MNPs by normalizing the measured ac
magnetic susceptibility using the high-frequency component of the ac
magnetic susceptibility, χ∞. This high-frequency real part depends only
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on the concentration of the MNPs, and for MNP labels of 100 nm in size
can be measured at frequencies as low as 10 kHz [80, 116]. As discussed
above, the stability of the MNP system is also critical. Signal variations
due to the MNP instability in the solution affect the quantification of
the RCPs and limits the LOD.
4.2 Turn-on detection of RCPs
An alternative approach to the turn-off detection strategy is to use the
differential ac susceptibility measurement technique introduced in the
Sec. 3.4.2. In this method, a single ac susceptibility measurement com-
pares the difference in the magnetic content of two samples filling two
independent microfluidic channels. When the same magnetic sample fills
both channels, the result is a zero-response signal. The amplitude of the
zero-response signal is less than 1% of the one from magnetic samples in
either of the two channels. As the difference in the concentration of the
magnetic content in the two sample increases, a signal appears whose
magnitude only increases with increasing difference in the two samples.
Therefore, the differential method is a turn-on technique which can be
used for detection of the RCPs independent of the initial concentration
of the MNP labels.
The principle of the differential ac susceptibility measurement is quite
similar to the Wheatstone bridge circuit. This circuit is used to measure
an unknown resistor or very small variations in a known resistance, Rx.
This is performed by having an adjustable resistor,R2 resistor, on the
left arm of the bridge and a known ratio on the right arm of the bridge
(R3/R4), Fig. 4.4 (a). In this circuit, when the ratio of the left arm of the
bridge (Rx/R2) is equal to the ratio of the two resistors in the right arm
(R3/R4), there is zero current flowing between points b and d (Vbd = 0)
and the bridge is balanced. The value of the unknown resistor is then
extracted from the three other known resistors:
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Vbd
Vac
= Rx
Rx +R2
− R4
R3 +R4
= 0
Rx =
R2 ×R3
R4
.
(4.3)
In this scenario, the excitation voltage across points a and c (Vac) can
be increased to improve the Vbd for sensitive measurement of any change
in the resistance of Rx without having a large background voltage drop
across b and d. If a known resistor is used instead of an adjustable re-
sistor in R2, one can use the the voltage drop Vbd (or current passing
between points a and b) to calculate the resistance of the unknown re-
sistor, Rx. In our differential ac susceptibility measurement setup, the
the SQUID measures voltage drop across b and d and the R2 and Rx re-
sistors are taken as the NC and the test sample, Fig. 4.4 (b). The known
ratio on the right arm of the bridge is equal to one as the gradiometer
compares the magnetic fluxes in its two loops. The SQUID voltage, in
this case, yields the difference between the two samples, which will be
zero if the test sample is the same as the NC sample.
Figure 4.4: (a) A Wheatstone bridge circuit. This circuit is used to either measure an
unknown resistor or changes in an known resistro, Rx, using two balanced arms of resistors.
The voltage is applied between points a and c and the adjusting resistor R2 is used to
null the voltage drop across points b and d. The unknown resistor can thus be calculated:
Rx = R2×R3R4 . (b) Equivalent circuit of the Wheatstone bridge for the differential ac magnetic
susceptibility measurement setup.
Turn-on detection of RCPs is reported earlier in the literature using
LTS SQUID magnetometers [87] and optomagnetic sensors [86]. The
turn-on detection signals in both of these cases are low-frequency signals
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(below 10 Hz) which appear due to the formation of large MNP-RCP
complexes. Measurements at low frequencies, however, have some draw-
backs. The SNR is lower at lower frequencies, which requires sampling
for longer periods. This makes the measurements longer and more com-
plicated. Using the differential ac susceptibility technique for turn-on
detection approach opens the whole frequency window for detection be-
cause it removes all the magnetic background from the unbound MNP
labels. This method also provides more information regarding the bind-
ing of the MNPs to the RCP compared to the turn-off approach. The
turn-on detection of RCPs using the differential ac susceptibility mea-
surement and further discussions regarding the binding kinetics are pre-
sented in papers III and IV.
4.2.1 Principle of turn-on detection
As discussed in the Sec. 3.4.2, the zero detection signal only starts to
build up if there are any discrepancies in the concentrations and/or size
distributions of the MNP samples in the two channels. Positive test sam-
ples containing different concentrations of RCPs of synthetic V. Cholerae
DNA targets are prepared (amplified for 20 minutes) and measured with
NC sample containing the same amount of MNPs (particle concentra-
tion of 250 µg/mL or 250 pM). The consumption of the MNPs in the
positive test sample due to the formation of MNP-RCP complex results
in a small difference in the MNPs’ concentration and size distribution in
the two samples. The formation of these complexes results in a non-zero-
response signal in the differential ac susceptibility measurement, which
increases with increasing RCP concentration in the positive test sample.
Fig. 4.5 (a) shows the turn-on detection of RCPs in the imaginary part
of differential ac susceptibility for an increasing concentrations of RCPs
from 0 to 90.4 pM. Assuming that the magnetic moment of individual
MNP does not depend on its volume, the amplitude of the imaginary
component of the ac susceptibility is proportional to the concentration
of the MNPs. The increase of the peak amplitude in the imaginary
component is only due to the change of the MNP size distribution in the
positive test sample. The MNPs in the positive test sample bind to the
RCPs, which increases their hydrodynamic size, and their characteristic
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relaxation moves to lower frequencies. The turn-on detection signal at
the Brownian relaxation frequency of the unbound MNPs (at 64.5 Hz)
is a function of the RCP concentration. The equilibrium fraction bound
is, therefore,
fbeq ∝ χ
′′
RCP
χ′′max
, (4.4)
where the χ′′max is the saturation signal (signal amplitude form the NC
sample in Ch. 1) and the χ′′RCP is the signal levels from different con-
centrations of RCPs, c.f. Fig. 4.5 (a). The RCP concentration depen-
dence of the fraction bound follows a logistic function behavior [123,
124] and is shown in Fig. 4.5 (b). The experimental LOD is 45 fM with
three orders of magnitude working dynamic range. The saturation of
the turn-on signal at 90.4 pM concentration of RCPs is due to nearly
complete consumption of the MNP labels by the RCPs (100% fraction
bound). Increasing the initial concentration of MNP labels would extend
the saturation level and the dynamic range of the biosensor. Although
the equilibrium fraction bound is not so high at the lower concentrations
of RCPs, the effective fraction bound measured by the SQUID sensor is
high (is equal to 50%) at low concentrations. This is due to the fact
that the differential measurement removes the signals from all the un-
bound MNPs from the positive test sample in Ch. 2. The detection
signal thus comes only from the MNP-RCP complexes in positive test
sample (Ch. 2) and the difference of unbound MNPs in the two chan-
nels. It is thus analogous to a washing step, where the excess number of
unbound labels is removed from the positive test sample, and results in
an effective binding fraction of 50%.
4.2.2 MNP-RCP complex relaxation dynamics
The MNP-RCP ensemble has two relaxation frequencies corresponding
to particles of two different sizes: (I) a high relaxation frequency (HRF)
which is characteristic of the unbound MNPs and (II) a low relaxation
frequency (LRF) which is a result of the MNP-RCP complexes or ag-
glomerates. Fitting a bi-modal Cole-Cole model to the data presented
in Fig. 4.5 (a) shows that the turn-on detection signal has two distinct
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Figure 4.5: Turn-on detection of RCPs using differential ac susceptibility measurements. (a)
Imaginary components of differential ac susceptibility versus the frequency for positive test
samples containing different concentrations of RCPs ranging from 0 to 90.4 pM in a 3.6 µL
sample volume. The NC sample fills Ch. 1, and the positive test samples fill Ch. 2. The
solid lines are bi-modal Cole-Cole model fitted to the data points at each RCP concentration.
(b) Equilibrium fraction bound is the normalized imaginary signal of the ac susceptibility at
64.5 Hz versus the concentration of the DNA targets (RCPs). The LOD is 45 fM, and the
working range spans more than 3 orders of magnitude in target concentration. Adapted from
paper III.
relaxation frequencies indeed. The LRF peak corresponds to the Brown-
ian relaxation of the MNP-RCP complex in the positive test sample and
the HRF peak is due to unbound MNPs and its magnitude corresponds
to the relative difference between unbound MNPs in the test and the
NC samples. Fig. 4.6 shows the frequencies of these two peaks extracted
by fitting the imaginary part of the differential ac susceptibility using a
bi-modal Brownian relaxation model as a function of RCP concentration
in the positive test sample.
The extracted frequencies from the bi-modal distribution in the turn-
on detection (the LRF and the HRF) implies that the smaller particles in
the MNP size distribution are more likely to take precedence in binding
during the hybridization with the RCPs. As the RCP concentration
increases, the values of both the LRF and the HRF reaches those of
the NC sample. This shows that the formation of the agglomerates
at higher concentrations of the RCPs takes the LRF distribution out
of the measurement window. If the LRF peak is taken as the turn-on
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Figure 4.6: The extracted LRF and HRF frequencies versus the RCP concentration in the
positive test sample. For high concentration of RCPs, both the LRF and HRF are shifted to
12 and 64.5 Hz, respectively. These two frequencies corresponds to the LRF and HRF of the
intrinsic bi-modal distribution of the NC sample. Adapted from paper IV.
detection signal, it is therefore important to remember that this signal
disappears at higher RCP concentrations due to agglomeration of the
MNPs and RCPs. The effect of RCP concentration and formation of the
agglomerates in the turn-on detection approach signal are discussed in
the paper IV.
We have also reported and discussed the effect of RCA time and RCP
concentration in both turn-on and turn-off approaches (paper IV). The
turn-on approach advantage over turn-off detection scheme is not limited
only to the LOD of target analyte (RCPs or target DNA molecules).
The turn-on approach can clearly distinguish the LRF and HRF peaks
corresponding to the MNP-RCP complexes and the unbound MNP even
at very low concentrations of RCPs. It also provides crucial information
regarding the binding process of the MNP to RCPs that can be used to
optimize the biosensor.
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CHAPTER 5
Conclusion
A nucleic acid magnetic biosensor based on a high-T c SQUID gradiome-
ter sensor has been demonstrated to have an excellent experimental limit
of detection (45 fM at SNR = 100), and fast turn-around time (60 min).
The DNA assay implements RCA for volume amplification of the DNA
target molecule into a long DNA coil or the rolling circle product (RCP).
The magnetic ac susceptibility measurement was used to detect the spe-
cific binding of the MNPs to the RCPs. An advantage of using the
ac susceptibility is low background signal. The detection signal is the
imaginary component of the ac susceptibility which is unique to the
MNP response.
The differential ac magnetic susceptibility technique developed in this
work, paper III, has overcome one of the challenges of turn-off detection
approaches in homogeneous magnetic biosensors: the magnetic back-
ground from the unbound MNPs. The method is a magnetic analogous
of the Wheatstone bridge which allows measurement of small differences
in two MNP solutions. The simultaneous measurement of the NC and
the test sample reduces the overall turn-around time of the assay. This
method also provides more information regarding the binding of the
MNPs to the RCPs even at low concentrations of the target which is not
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available in turn-off detection approaches (paper IV). The measurement
technique is a paradigm shift in homogeneous magnetic biosensors.
One of the drawbacks of our sensor, however, is the need for liquid ni-
trogen to operate our high-T c SQUID. As presented in paper I, we have
shown successful operation of the high-T c SQUID with great noise per-
formance utilizing a commercial two-stage micro electro mechanical sys-
tems (MEMS) based Joule-Thomson micro-cooler (DEMCON Kryoz).
The micro-cooler offers long operation time, simple usage, and temper-
ature stability and adjustment. With proper magnetic shielding, the
SQUID sensor can be operated stably over a long time in the micro-
cooler using only nitrogen gas bottles.
The sensitivity of our differential magnetic bioassay is determined by
the quality of the MNP system rather than the magnetic sensitivity
of our SQUID sensor. This means that one could use other magnetic
sensors with lower sensitivity compare to SQUIDs to reach the same
limits of detection. The induction coil system presented in Paper V is
an excellent example. It already uses a first order gradiometer but only
to remove the contributions of the applied excitation field. Implementing
the differential ac susceptibility measurement technique on this system
would boost its sensitivity by increasing the SNR levels.
Further work is required for the high-T c SQUID biosensor to be imple-
mented for practical field applications. In the sensor part, this includes
using a closed cycle dry cooler to rule out the need for liquid or gas
nitrogen completely. On the other hand, the nucleic acid assay should
be fully implemented on a lab-on-a-chip to automate the diagnostic test
and eliminate any need of trained staffs or clinical labs.
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RCA protocol
A.1 Ligation and RCA
Throughout this work, synthetic DNA targets of Vibrio Cholerae is used.
The DNA sequences for the synthetic target and their corresponding pad-
lock probe and detection oligonucleotide which are necessary to perform
RCA are presented in Table A.1. The procedure which has been used to
produce final RCPs of 5 nM concentration is explained in the following
sections. The 5 nM concentration corresponds to the initial concentra-
tion of the padlock probes. Considering the 22.6% success rate of the
amplification process [95], the final concentration is 1.13 nM.
In order to form a padlock probe-target complex, 3 µL synthesized
target DNA (1 µM) is hybridized and ligated at 37 ◦C for 15 min with
1 µL padlock probe (1 µM) in a solution consisting of 2.5 µL of 20 mM
adenosine triphosphate (ATP), 1 µL T4 DNA ligase (1U/µL, enzyme
unit per micro liter), and 5 µL of Φ29 DNA polymerase buffer in a
total volume of 50 µL. The circularized padlock probe-target complex
is now ready for amplification. To amplify the padlock probes, 25 µL
ligation mix consisting of 20 nM concentration of padlock probes are
copied by 0.4 µL Φ29 polymerase for 1 hour at 37 ◦C in a solution with
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4 µL dNTP (2.5 mM), 6 µL bovine serum albumin (BSA) (2 µg/mL),
6 µL Φ29 polymerase buffer and water in 60 µL reaction volume. The
enzyme is thermally inactivated at 65◦C for 5 min. 40 µL hybridization
buffer of 1 M tris(hydroxymethyl) aminomethane hydrochloride (Tris-
HCl) (pH 8.0), 0.5 M ethylenediaminetetraacetic acid (EDTA), Tween-
20 (10%) and 5 M sodium chloride (NaCl) is added at the end to bring
the concentration of RCPs to 5 nM [80]. The RCP solution is now ready
to be labelled for detection.
Table A.1: DNA sequences for the synthetic V. Cholerae target used in this thesis and its
corresponding padlock probe and the detection oligonucleotide.
Oligos Sequences from 5′ to 3′
Target CCC TGG GCT CAA CCT AGG AAT CGC ATT TG
Padlock probe
TAG GTT GAG CCC AGG GAC TTC TAG AGT GTA CCG
ACC TCA GTA GCC GTG ACT ATC GAC TTG TTG ATG
TCA TGT GTC GCA CCA AAT GCG ATT CC
Detection probe TTT TTT TTT TTT TTT TTT TTG TTG ATG TCA TGTGTC GCAC
A.2 Functionalization of MNPs
The coupling of the oligonucleotides to the MNPs is performed in a vol-
ume of 100 µL. The MNPs are washed twice using a magnetic separator
in a washing buffer with 1 M Tris-HCl (pH 8.0), 0.5 M EDTA, Tween-
20 (10%) and 5 M NaCl. The MNPs are then resuspended in 50 µL
washing buffer. 6 µL of the oligonucleotide with 10 µM concentration
is added to the resuspended MNPs, and the mixture is vortexed and
incubated at room temperature for 30 min. After the incubation the
MNPs are rewashed in the washing buffer for two times using a perma-
nent magnet and resuspended to the original volume of 100 µL in PBS
with a pH of 7.4. With the oligonucleotides bound to the surface, the
MNPs are functionalized and can specifically bind to the backbone of the
padlock probe amplified by the RCA method (i.e., RCPs). The MNP
systems used in our studies, according to its datasheet, are suspended
iron oxide-based streptavidin-coated multi-core particles with a median
diameter of 80 or 100 nm for the core (micromod Partikeltechnologie
GmbH, Rostock, Germany).
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A.3 Labelling of RCPs
In this study, we have labeled the RCPs with the fluorescent markers
(atto-488) or MNPs. The atto-488 are attached to the 3′ side of the
detection probe oligonucleotide and have their excitation wavelength in
the range of the laser wavelength used in the NTA setup. The detec-
tion probe oligonucleotides also have a biotinylated side in its 5′ which
can bind to the streptavidin coating of the MNPs, functionalizing them
for specific binding to the RCPs. In order to conjugate the fluorescent
or the magnetic markers to the RCPs, the markers and the RCPs are
mixed, and the solution is incubated for 20-30 min at 55 ◦C. Different
concentrations of RCPs are prepared by diluting the RCP stock solution
with hybridization buffer.
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